,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,D,"N-degron, 1-3, ELM",,,,,,,,,,,
1,2,E,A,,,,,,,,,,D,"N-degron, 1-3, ELM",,COSMIC,,,"hg38,12:131895006-131895006","hg38,12:g.131895006A>C",0.065,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
2,3,P,L,,,,,,,,,,C,"N-degron, 1-3, ELM",,COSMIC,,,"hg38,12:131895009-131895009","hg38,12:g.131895009C>T",0.131,thyroid,carcinoma,,
3,4,G,,,,,,,,,,,C,,,,,,,,,,,,
4,5,R,,,,,,,,,,,C,,,,,,,,,,,,
5,6,G,R,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,COSMIC,,,"hg38,12:131895017-131895017","hg38,12:g.131895017G>C",0.049,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
6,7,G,,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,,,,,,,,,,
7,8,T,P,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,COSMIC,,,"hg38,12:131895023-131895023","hg38,12:g.131895023A>C",0.124,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
8,9,E,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,COSMIC,,,"hg38,12:131895027-131895027","hg38,12:g.131895027A>T",0.372,thyroid,carcinoma,,
9,10,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,,,,,,,,,,
10,11,V,,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,,,,,,,,,,
11,12,G,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 6-12, ELM",,"cBioPortal,COSMIC","difg_glass_2019, gbm_tcga_pan_can_atlas_2018, lgg_ucsf_2014","Diffuse Glioma, Glioblastoma Multiforme","hg19,12:132379581-132379581, hg38,12:131895036-131895036","hg19,12:g.132379581G>A, hg38,12:g.131895036G>A",0.308,"central_nervous_system, brain, thyroid","carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000000000000000,0.0000341600054656
12,13,K,T,,,Ubq,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132379584-132379584","hg19,12:g.132379584A>C",0.137,,,,
13,14,F,L,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,12:132379588-132379588, hg38,12:131895043-131895043","hg19,12:g.132379588C>G, hg38,12:g.131895043C>G",0.205,"urinary_tract, bladder",carcinoma,,
14,15,E,A,,,,,,,,,,C,,,COSMIC,,,"hg38,12:131895045-131895045","hg38,12:g.131895045A>C",0.384,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
15,16,F,,,,,,,,,,,C,,,,,,,,,,,,
16,17,S,,,,,,,,,,,C,"NRD cleavage site, 17-19, ELM",,,,,,,,,,,
17,18,R,S,,,,,,,,,,C,"NRD cleavage site, 17-19, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132379598-132379598, hg38,12:131895053-131895053","hg19,12:g.132379598C>A, hg38,12:g.131895053C>A",0.077,skin,malignant_melanoma,,
18,19,K,N,,,,,,,,,,C,"NRD cleavage site, 17-19, ELM",,COSMIC,,,"hg38,12:131895058-131895058","hg38,12:g.131895058G>T",0.125,large_intestine,"carcinoma, adenocarcinoma",,
19,20,D,,,,,,,,,,,C,,,,,,,,,,,,
20,21,L,P,,,,,,,,,,C,,,COSMIC,,,"hg38,12:131895063-131895063","hg38,12:g.131895063T>C",0.366,thyroid,carcinoma,,
21,22,I,,,,,,,,,,,C,,,,,,,,,,,,
22,23,G,,,,,,,,,,,C,,,,,,,,,,,,
23,24,H,,,,,,,,,,,C,,,,,,,,,,,,
24,25,G,S,,,,,,,,,,C,,,COSMIC,,,"hg38,12:131895074-131895074","hg38,12:g.131895074G>A",0.875,thyroid,carcinoma,,
25,26,A,,,,,,,,,,,C,,,,,,,,,,,,
26,27,F,,,,,,,,,,,C,"Pex14 ligand motif, 27-31, ELM",,,,,,,,,,,
27,28,A,V,,,,,,,,,,C,"Pex14 ligand motif, 27-31, ELM",,"cBioPortal,COSMIC","gbm_tcga, gbm_tcga_pan_can_atlas_2018, lgggbm_tcga_pub","Diffuse Glioma, Glioblastoma Multiforme","hg19,12:132379629-132379629, hg38,12:131895084-131895084","hg19,12:g.132379629C>T, hg38,12:g.131895084C>T",0.377,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
28,29,V,,,,,,,,,,,C,"Pex14 ligand motif, 27-31, ELM",,,,,,,,,,,
29,30,V,,,,,,,,,,,C,"Pex14 ligand motif, 27-31, ELM",,,,,,,,,,,
30,31,F,,,,,,,,,,,C,"Pex14 ligand motif, 27-31, ELM",,,,,,,,,,,
31,32,K,,,,,,,,,,,C,,,,,,,,,,,,
32,33,G,,,,,,,,,,,C,,,,,,,,,,,,
33,34,R,C,,,,,,,,,,C,"MAPK docking motifs, 34-43, ELM",,COSMIC,,,"hg38,12:131895101-131895101","hg38,12:g.131895101C>T",0.271,thyroid,carcinoma,0.0000939414056139,
34,35,H,,,,,,,,,,,C,"MAPK docking motifs, 34-43, ELM",,,,,,,,,,,
35,36,R,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
36,37,E,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
37,38,K,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
38,39,H,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
39,40,D,G,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,"cBioPortal,COSMIC",prad_mich,Prostate Adenocarcinoma,"hg19,12:132380153-132380153, hg38,12:131895608-131895608","hg19,12:g.132380153A>G, hg38,12:g.131895608A>G",0.111,prostate,"carcinoma, adenocarcinoma",0.0000079748632311,
40,40,D,Y,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,12:132380152-132380152","hg19,12:g.132380152G>T",0.215,,,,
41,41,L,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
42,42,E,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
43,43,V,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 34-43, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
44,44,A,D,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 36-45, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,12:132380165-132380165, hg38,12:131895620-131895620","hg19,12:g.132380165C>A, hg38,12:g.131895620C>A",0.673,lung,"carcinoma, squamous_cell_carcinoma",,
45,45,V,,,,,,,,,,,C,"MAPK docking motifs, 36-45, ELM|MAPK docking motifs, 38-45, ELM|MAPK docking motifs, 36-45, ELM",,,,,,,,,,,
46,46,K,,,,Ubq,,,,,,,C,"USP7 binding motif, 46-50, ELM",,,,,,,,,,,
47,47,C,R,,,,,,,,,,C,"USP7 binding motif, 46-50, ELM",,COSMIC,,,"hg38,12:131895628-131895628","hg38,12:g.131895628T>C",0.223,breast,"carcinoma, ductal_carcinoma",,
48,48,I,,,,,,,,,,,C,"USP7 binding motif, 46-50, ELM",,,,,,,,,,,
49,49,N,,,,,,,,,,,C,"USP7 binding motif, 46-50, ELM",,,,,,,,,,,
50,50,K,,,,,,,,,,,C,"USP7 binding motif, 46-50, ELM",,,,,,,,,,,
51,51,K,,,,,,,,,,,C,"USP7 binding motif, 51-55, ELM",,,,,,,,,,,
52,52,N,,,,,,,,,,,C,"USP7 binding motif, 51-55, ELM",,,,,,,,,,,
53,53,L,P,,,,,,,,,,C,"USP7 binding motif, 51-55, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132380192-132380192, hg38,12:131895647-131895647","hg19,12:g.132380192T>C, hg38,12:g.131895647T>C",0.451,endometrium,"carcinoma, endometrioid_carcinoma",,
54,54,A,,,,,,,,,,,C,"USP7 binding motif, 51-55, ELM",,,,,,,,,,,
55,55,K,,,,Ubq,,,,,,,C,"USP7 binding motif, 51-55, ELM",,,,,,,,,,,
56,56,S,Y,,,,,,,,,,C,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,12:132380201-132380201, hg38,12:131895656-131895656","hg19,12:g.132380201C>A, hg38,12:g.131895656C>A",0.393,"endometrium, large_intestine, caecum","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,
57,57,Q,,,,,,,,,,,C,,,,,,,,,,,,
58,58,T,,P,,,,,,,,,S,,,,,,,,,,,,
59,59,L,,,,,,,,,,,C,,,,,,,,,,,,
60,60,L,,,,,,,,,,,S,,,,,,,,,,,,
61,61,G,,,,,,,,,,,S,,,,,,,,,,,,
62,62,K,,,,Ubq,,,,,,,S,"PCSK cleavage site, 62-66, ELM",,,,,,,,,,,
63,63,E,,,,,,,,,,,S,"PCSK cleavage site, 62-66, ELM",,,,,,,,,,,
64,64,I,,,,,,,,,,,S,"PCSK cleavage site, 62-66, ELM",,,,,,,,,,,
65,65,K,,,,,,,,,,,S,"PCSK cleavage site, 62-66, ELM|PCSK cleavage site, 65-69, ELM",,,,,,,,,,,
66,66,I,,,,,,,,,,,S,"PCSK cleavage site, 62-66, ELM|PCSK cleavage site, 65-69, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
67,67,L,,,,,,,,,,,S,"PCSK cleavage site, 65-69, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
68,68,K,,,,,,,,,,,S,"PCSK cleavage site, 65-69, ELM|PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
69,69,E,,,,,,,,,,,S,"PCSK cleavage site, 65-69, ELM|PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
70,70,L,,,,,,,,,,,S,"PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
71,71,K,,,,,,,,,,,S,"PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM|Binding motif for UBA3 adenylation domain, 66-71, ELM",,,,,,,,,,,
72,72,H,D,,,,,,,,,,S,"PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM",,COSMIC,,,"hg38,12:131895792-131895792","hg38,12:g.131895792C>G",0.837,"skin, mucosal, female_genitourinary_system",malignant_melanoma,,
73,72,H,N,,,,,,,,,,S,"PCSK cleavage site, 68-72, ELM|MAPK docking motifs, 68-78, ELM",,COSMIC,,,"hg38,12:131895792-131895792","hg38,12:g.131895792C>A",0.670,"skin, mucosal, female_genital_tract_(site_indeterminate)",malignant_melanoma,,
74,73,E,D,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,12:132380342-132380342, hg38,12:131895797-131895797","hg19,12:g.132380342A>C, hg38,12:g.131895797A>C",0.116,large_intestine,"carcinoma, adenocarcinoma",,
75,73,E,K,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM",,"cBioPortal,COSMIC",cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132380340-132380340, hg38,12:131895795-131895795","hg19,12:g.132380340G>A, hg38,12:g.131895795G>A",0.256,lung,"carcinoma, adenocarcinoma",0.0000556854883617,
76,74,N,,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,,,,,,,,,,
77,75,I,,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,,,,,,,,,,
78,76,V,,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,,,,,,,,,,
79,77,A,D,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132380353-132380353, hg38,12:131895808-131895808","hg19,12:g.132380353C>A, hg38,12:g.131895808C>A",0.236,skin,malignant_melanoma,,
80,77,A,T,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,12:132380352-132380352","hg19,12:g.132380352G>A",0.200,,,,
81,78,L,M,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,12:132380355-132380355, hg38,12:131895810-131895810","hg19,12:g.132380355C>A, hg38,12:g.131895810C>A",0.338,lung,"carcinoma, squamous_cell_carcinoma",,
82,78,L,Q,,,,,,,,,,S,"MAPK docking motifs, 68-78, ELM|Rb pocket AB groove ligand, 73-81, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132380356-132380356, hg38,12:131895811-131895811","hg19,12:g.132380356T>A, hg38,12:g.131895811T>A",0.539,stomach,"carcinoma, adenocarcinoma",,
83,79,Y,,,,,,,,,,,S,"Rb pocket AB groove ligand, 73-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 79-82, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,,,,,,,,,,
84,80,D,,,,,,,,,,,S,"Atg8 protein family ligands, 80-89, ELM|Rb pocket AB groove ligand, 73-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 79-82, ELM|SUMO interaction site, 73-80, ELM|SUMO interaction site, 74-80, ELM",,,,,,,,,,,
85,81,F,L,,,,,,,,,,S,"Atg8 protein family ligands, 80-89, ELM|Rb pocket AB groove ligand, 73-81, ELM|Phosphotyrosine ligands bound by SH2 domains, 79-82, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,12:132380364-132380364, hg38,12:131895819-131895819","hg19,12:g.132380364T>C, hg38,12:g.131895819T>C",0.215,"urinary_tract, bladder",carcinoma,,
86,82,Q,,,,,,,,,,,S,"Atg8 protein family ligands, 80-89, ELM|Phosphotyrosine ligands bound by SH2 domains, 79-82, ELM",,,,,,,,,,,
87,83,E,K,,,,,,,,,,C,"Atg8 protein family ligands, 80-89, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,COSMIC,,,"hg38,12:131906892-131906892","hg38,12:g.131906892G>A",0.566,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
88,84,M,,,,,,,,,,,C,"Atg8 protein family ligands, 80-89, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,,,,,,,,,,
89,85,A,V,,,,,,,,,,C,"Atg8 protein family ligands, 80-89, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132391444-132391444","hg19,12:g.132391444C>T",0.085,,,0.0000039794659557,
90,86,N,T,,,,,,,,,,C,"Atg8 protein family ligands, 80-89, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,12:132391447-132391447, hg38,12:131906902-131906902","hg19,12:g.132391447A>C, hg38,12:g.131906902A>C",0.049,endometrium,"carcinoma, endometrioid_carcinoma",,
91,87,S,C,,,,,,,,,,C,"Atg8 protein family ligands, 80-89, ELM|Atg8 protein family ligands, 87-94, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,12:132391450-132391450","hg19,12:g.132391450C>G",0.156,,,0.0000397952930127,
92,88,V,,,,,,,,,,,S,"Atg8 protein family ligands, 80-89, ELM|Atg8 protein family ligands, 87-94, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM",,,,,,,,,,,
93,89,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 80-89, ELM|Atg8 protein family ligands, 87-94, ELM|PTB ligand, 83-90, ELM|PTB ligand, 83-89, ELM|Phosphotyrosine ligands bound by SH2 domains, 89-92, ELM|Y-based sorting signal, 89-92, ELM",,,,,,,,,,,
94,90,L,,,,,,,,,,,S,"Atg8 protein family ligands, 87-94, ELM|PTB ligand, 83-90, ELM|Phosphotyrosine ligands bound by SH2 domains, 89-92, ELM|Y-based sorting signal, 89-92, ELM",,,,,,,,,,,
95,91,V,,,,,,,,,,,S,"Atg8 protein family ligands, 87-94, ELM|Phosphotyrosine ligands bound by SH2 domains, 89-92, ELM|Y-based sorting signal, 89-92, ELM",,,,,,,,,,,
96,92,M,,,,,,,,,,,S,"Atg8 protein family ligands, 87-94, ELM|Phosphotyrosine ligands bound by SH2 domains, 89-92, ELM|Y-based sorting signal, 89-92, ELM",,,,,,,,,,,
97,93,E,Q,,,,,,,,,,S,"Atg8 protein family ligands, 87-94, ELM",,COSMIC,,,"hg38,12:131906922-131906922","hg38,12:g.131906922G>C",0.540,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
98,94,Y,C,,,,,,,,,,S,"Atg8 protein family ligands, 87-94, ELM|Phosphotyrosine ligands bound by SH2 domains, 94-97, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132392041-132392041","hg19,12:g.132392041A>G",0.648,,,,
99,95,C,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 94-97, ELM",,,,,,,,,,,
100,96,N,D,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 94-97, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132392046-132392046, hg38,12:131907501-131907501","hg19,12:g.132392046A>G, hg38,12:g.131907501A>G",0.376,endometrium,"carcinoma, endometrioid_carcinoma",,
101,96,N,T,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 94-97, ELM",,COSMIC,,,"hg38,12:131907502-131907502","hg38,12:g.131907502A>C",0.363,lung,"carcinoma, acinar_adenocarcinoma",,
102,97,G,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 94-97, ELM",,,,,,,,,,,
103,98,G,,,,,,,,,,,S,,,,,,,,,,,,
104,99,D,,,,,,,,,,,S,,,,,,,,,,,,
105,100,L,,,,,,,,,,,S,,,,,,,,,,,,
106,101,A,T,,,,,,,,,,S,,,"cBioPortal,COSMIC","luad_mskcc_2015, mixed_allen_2018, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,12:132392061-132392061, hg38,12:131907516-131907516","hg19,12:g.132392061G>A, hg38,12:g.131907516G>A",0.373,endometrium,"carcinoma, endometrioid_carcinoma",,
107,101,A,V,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132392062-132392062","hg19,12:g.132392062C>T",0.379,,,,
108,102,D,N,,,,,,,,,,C,,,"cBioPortal,COSMIC","lgg_tcga, lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub",Diffuse Glioma,"hg19,12:132392064-132392064, hg38,12:131907519-131907519","hg19,12:g.132392064G>A, hg38,12:g.131907519G>A",0.364,"central_nervous_system, brain",glioma,0.0000080606808051,
109,103,Y,H,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM|Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM",,cBioPortal,nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,12:132392067-132392067","hg19,12:g.132392067T>C",0.704,,,,
110,104,L,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM|Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM",,,,,,,,,,,
111,105,H,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM|Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM",,,,,,,,,,,
112,106,A,V,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM|Phosphotyrosine ligands bound by SH2 domains, 103-106, ELM",,cBioPortal,ucs_jhu_2014,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,12:132393189-132393189","hg19,12:g.132393189C>T",0.146,,,,
113,107,M,,,,,,,,,,,C,"FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
114,108,R,H,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,cBioPortal,"ccle_broad_2019, pancan_pcawg_2020",Mixed Cancer Types,"hg19,12:132393195-132393195","hg19,12:g.132393195G>A",0.282,,,,
115,109,T,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
116,110,L,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
117,111,S,,P,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
118,112,E,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
119,113,D,E,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM|FHA phosphopeptide ligands, 107-113, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,12:132393211-132393211, hg38,12:131908666-131908666","hg19,12:g.132393211C>A, hg38,12:g.131908666C>A",0.318,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
120,114,T,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM",,,,,,,,,,,
121,115,I,,,,,,,,,,,S,"APCC-binding Destruction motifs, 115-123, ELM|14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM",,,,,,,,,,,
122,116,R,S,,,,,,,,,,S,"PCSK cleavage site, 116-120, ELM|APCC-binding Destruction motifs, 115-123, ELM|14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,12:132393220-132393220","hg19,12:g.132393220G>T",0.421,,,,
123,117,L,,,,,,,,,,,S,"PCSK cleavage site, 116-120, ELM|APCC-binding Destruction motifs, 115-123, ELM|14-3-3 binding phosphopeptide motif, 108-117, ELM|FHA phosphopeptide ligands, 112-118, ELM",,,,,,,,,,,
124,118,F,,,,,,,,,,,S,"PCSK cleavage site, 116-120, ELM|APCC-binding Destruction motifs, 115-123, ELM|FHA phosphopeptide ligands, 112-118, ELM",,,,,,,,,,,
125,119,L,,,,,,,,,,,S,"PCSK cleavage site, 116-120, ELM|APCC-binding Destruction motifs, 115-123, ELM",,,,,,,,,,,
126,120,Q,H,,,,,,,,,,S,"PCSK cleavage site, 116-120, ELM|APCC-binding Destruction motifs, 115-123, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132393232-132393232, hg38,12:131908687-131908687","hg19,12:g.132393232G>T, hg38,12:g.131908687G>T",0.250,oesophagus,"carcinoma, adenocarcinoma",,
127,121,Q,,,,,,,,,,,S,"APCC-binding Destruction motifs, 115-123, ELM",,,,,,,,,,,
128,122,I,,,,,,,,,,,S,"APCC-binding Destruction motifs, 115-123, ELM",,,,,,,,,,,
129,123,A,V,,,,,,,,,,S,"APCC-binding Destruction motifs, 115-123, ELM",,COSMIC,,,"hg38,12:131908695-131908695","hg38,12:g.131908695C>T",0.202,stomach,"carcinoma, intestinal_adenocarcinoma",0.0000134066228717,
130,124,G,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,,,,,,,,,,
131,125,A,T,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coad_cptac_2019, coadread_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,12:132393245-132393245, hg38,12:131908700-131908700","hg19,12:g.132393245G>A, hg38,12:g.131908700G>A",0.741,"large_intestine, large_intestine, caecum, large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
132,126,M,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,,,,,,,,,,
133,127,R,W,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,COSMIC,,,"hg38,12:131908706-131908706","hg38,12:g.131908706C>T",0.443,thyroid,carcinoma,0.0000000000000000,0.0000638732754216
134,128,L,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,,,,,,,,,,
135,129,L,,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 124-129, ELM",,,,,,,,,,,
136,130,H,,,,,,,,,,,S,,,,,,,,,,,,
137,131,S,,P,,,,,,,,,S,,,,,,,,,,,,
138,132,K,,,,,,,,,,,S,,,,,,,,,,,,
139,133,G,,,,,,,,,,,S,,,,,,,,,,,,
140,134,I,,,,,,,,,,,S,,,,,,,,,,,,
141,135,I,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,12:132393275-132393275, hg38,12:131908730-131908730","hg19,12:g.132393275A>G, hg38,12:g.131908730A>G",0.140,"urinary_tract, bladder",carcinoma,,
142,136,H,,,,,,,,,,,S,,,,,,,,,,,,
143,137,R,C,,,,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132393281-132393281, hg38,12:131908736-131908736","hg19,12:g.132393281C>T, hg38,12:g.131908736C>T",0.843,"breast, large_intestine, colon","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",,
144,137,R,H,,,,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, pptc_2019, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucs_jhu_2014","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,12:132393282-132393282, hg38,12:131908737-131908737","hg19,12:g.132393282G>A, hg38,12:g.131908737G>A",0.796,stomach,"carcinoma, adenocarcinoma",0.0000042152829298,
145,138,D,N,,,,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, paad_tcga, paad_tcga_pan_can_atlas_2018","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma","hg19,12:132393284-132393284, hg38,12:131908739-131908739","hg19,12:g.132393284G>A, hg38,12:g.131908739G>A",0.769,lung,"carcinoma, squamous_cell_carcinoma",0.0000000000000000,
146,139,L,P,,,,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,COSMIC,,,"hg38,12:131908743-131908743","hg38,12:g.131908743T>C",0.874,thyroid,carcinoma,,
147,140,K,,,,Ubq,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,,,,,,,,,,
148,141,P,L,,,,,,,,,,S,"PCSK cleavage site, 137-141, ELM|MAPK docking motifs, 137-146, ELM",,COSMIC,,,"hg38,12:131908749-131908749","hg38,12:g.131908749C>T",0.689,liver,"carcinoma, hepatocellular_carcinoma",,
149,142,Q,,,,,,,,,,,S,"MAPK docking motifs, 137-146, ELM",,,,,,,,,,,
150,143,N,,,,,,,,,,,S,"MAPK docking motifs, 137-146, ELM",,,,,,,,,,,
151,144,I,,,,,,,,,,,S,"MAPK docking motifs, 137-146, ELM",,,,,,,,,,,
152,145,L,M,,,,,,,,,,S,"MAPK docking motifs, 137-146, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,12:132393305-132393305","hg19,12:g.132393305C>A",0.447,,,,
153,146,L,,,,,,,,,,,S,"MAPK docking motifs, 137-146, ELM",,,,,,,,,,,
154,147,S,F,,,,,,,,,,S,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132393312-132393312, hg38,12:131908767-131908767","hg19,12:g.132393312C>T, hg38,12:g.131908767C>T",0.583,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",,
155,147,S,P,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132393311-132393311","hg19,12:g.132393311T>C",0.628,,,,
156,148,N,T,,,,,,,,,,C,,,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132393315-132393315","hg19,12:g.132393315A>C",0.190,,,0.0000302694848999,
157,149,P,,,,,,,,,,,C,,,,,,,,,,,,
158,150,A,T,,,,,,,,,,C,,,cBioPortal,"cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,12:132393320-132393320","hg19,12:g.132393320G>A",0.043,,,,
159,151,G,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,12:132393324-132393324, hg38,12:131908779-131908779","hg19,12:g.132393324G>A, hg38,12:g.131908779G>A",0.263,,malignant_melanoma,0.0000085323504066,
160,151,G,R,,,,,,,,,,C,,,COSMIC,,,"hg38,12:131908778-131908778","hg38,12:g.131908778G>C",0.163,thyroid,carcinoma,,
161,151,G,S,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,12:132393323-132393323, hg38,12:131908778-131908778","hg19,12:g.132393323G>A, hg38,12:g.131908778G>A",0.157,,malignant_melanoma,,
162,152,R,C,,,,,,,,,,C,"NRD cleavage site, 152-154, ELM",,cBioPortal,"coad_caseccc_2015, coad_cptac_2019",Colon Adenocarcinoma,"hg19,12:132393326-132393326","hg19,12:g.132393326C>T",0.220,,,0.0000042402347394,
163,152,R,L,,,,,,,,,,C,"NRD cleavage site, 152-154, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132393327-132393327, hg38,12:131908782-131908782","hg19,12:g.132393327G>T, hg38,12:g.131908782G>T",0.226,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
164,153,R,H,,,,,,,,,,C,"NRD cleavage site, 152-154, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coadread_dfci_2016","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,12:132393330-132393330, hg38,12:131908785-131908785","hg19,12:g.132393330G>A, hg38,12:g.131908785G>A",0.124,large_intestine,"carcinoma, adenocarcinoma",0.0000042432934747,
165,154,A,S,,,,,,,,,,C,"NRD cleavage site, 152-154, ELM|Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,12:132393332-132393332, hg38,12:131908787-131908787","hg19,12:g.132393332G>T, hg38,12:g.131908787G>T",0.060,liver,"carcinoma, hepatocellular_carcinoma",,
166,155,N,,,,,,,,,,,C,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,,,,,,,,,,
167,156,P,S,,,,,,,,,,C,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132393338-132393338","hg19,12:g.132393338C>T",0.065,,,0.0000126464884917,
168,157,N,,,,,,,,,,,C,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,,,,,,,,,,
169,158,S,,P,,,,,,,,,C,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,,,,,,,,,,
170,159,I,,,,,,,,,,,S,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,,,,,,,,,,
171,160,R,L,,,,,,,,,,S,"Extracellular side LRP5 and -6 binding motif, 154-160, ELM",,COSMIC,,,"hg38,12:131908806-131908806","hg38,12:g.131908806G>T",0.265,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
172,161,V,I,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132393353-132393353","hg19,12:g.132393353G>A",0.073,,,0.0000000000000000,
173,162,K,N,,,Ubq,,,Ac,,,,S,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,12:132393358-132393358","hg19,12:g.132393358G>C",0.741,,,,
174,163,I,,,,,,,,,,,S,,,,,,,,,,,,
175,164,A,,,,,,,,,,,S,,,,,,,,,,,,
176,165,D,N,,,,,,,,,,S,,,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,12:132393445-132393445, hg38,12:131908900-131908900","hg19,12:g.132393445G>A, hg38,12:g.131908900G>A",0.884,soft_tissue,sarcoma,,
177,166,F,,,,,,,,,,,S,,,,,,,,,,,,
178,167,G,A,,,,,,,,,,S,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132393452-132393452, hg38,12:131908907-131908907","hg19,12:g.132393452G>C, hg38,12:g.131908907G>C",0.910,lung,"carcinoma, squamous_cell_carcinoma",,
179,168,F,,,,,,,,,,,S,,,,,,,,,,,,
180,169,A,T,,,,,,,,,,S,,,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018, pancan_pcawg_2020, prad_su2c_2019","Mixed Cancer Types, Papillary Renal Cell Carcinoma, Prostate Adenocarcinoma","hg19,12:132393457-132393457, hg38,12:131908912-131908912","hg19,12:g.132393457G>A, hg38,12:g.131908912G>A",0.751,kidney,"carcinoma, papillary_renal_cell_carcinoma",,
181,169,A,V,,,,,,,,,,S,,,cBioPortal,"stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132393458-132393458","hg19,12:g.132393458C>T",0.706,,,,
182,170,R,W,,,,,,,,,,S,,,COSMIC,,,"hg38,12:131908915-131908915","hg38,12:g.131908915C>T",0.481,stomach,"carcinoma, intestinal_adenocarcinoma",,
183,171,Y,H,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 171-174, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132393463-132393463, hg38,12:131908918-131908918","hg19,12:g.132393463T>C, hg38,12:g.131908918T>C",0.121,skin,malignant_melanoma,,
184,172,L,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 171-174, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132393465-132393466, hg19,12:132393466-132393466","hg19,12:g.132393465_132393466delinsTT, hg19,12:g.132393466C>T",0.430,,,,
185,173,Q,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 171-174, ELM",,,,,,,,,,,
186,174,S,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 171-174, ELM",,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,12:132393473-132393473","hg19,12:g.132393473G>A",0.130,,,,
187,175,N,,,,,,,,,,,C,,,,,,,,,,,,
188,176,M,,,,,,,,,,,C,,,,,,,,,,,,
189,177,M,V,,,,,,,,,,C,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132393481-132393481, hg38,12:131908936-131908936","hg19,12:g.132393481A>G, hg38,12:g.131908936A>G",0.632,stomach,"carcinoma, adenocarcinoma",,
190,178,A,,,,,,,,,,,C,,,,,,,,,,,,
191,179,A,,,,,,,,,,,C,,,,,,,,,,,,
192,180,T,I,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132393491-132393491","hg19,12:g.132393491C>T",0.808,,,,
193,181,L,,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,,,,,,,,,,
194,182,C,,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,,,,,,,,,,
195,183,G,V,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132393500-132393500, hg38,12:131908955-131908955","hg19,12:g.132393500G>T, hg38,12:g.131908955G>T",0.766,lung,"carcinoma, squamous_cell_carcinoma",,
196,184,S,F,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,12:132393503-132393503, hg38,12:131908958-131908958","hg19,12:g.132393503C>T, hg38,12:g.131908958C>T",0.797,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
197,185,P,L,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,"cBioPortal,COSMIC",gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132393506-132393506, hg38,12:131908961-131908961","hg19,12:g.132393506C>T, hg38,12:g.131908961C>T",0.610,"large_intestine, colon","carcinoma, adenocarcinoma",,
198,186,M,,,,,,,,,,,S,"WW domain ligands, 181-186, ELM",,,,,,,,,,,
199,187,Y,,,,,,,,,,,S,,,,,,,,,,,,
200,188,M,,,,,,,,,,,S,,,,,,,,,,,,
201,189,A,,,,,,,,,,,S,,,,,,,,,,,,
202,190,P,,,,,,,,,,,S,,,,,,,,,,,,
203,191,E,G,,,,,,,,,,S,,,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,12:132393688-132393688","hg19,12:g.132393688A>G",0.881,,,,
204,192,V,,,,,,,,,,,S,,,,,,,,,,,,
205,193,I,,,,,,,,,,,S,,,,,,,,,,,,
206,194,M,V,,,,,,,,,,S,,,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,12:132393696-132393696","hg19,12:g.132393696A>G",0.373,,,,
207,195,S,P,,,,,,,,,,S,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132393699-132393699","hg19,12:g.132393699T>C",0.531,,,,
208,196,Q,,,,,,,,,,,S,,,,,,,,,,,,
209,197,H,,,,,,,,,,,S,,,,,,,,,,,,
210,198,Y,,,,,,,,,,,S,,,,,,,,,,,,
211,199,D,,,,,,,,,,,S,,,,,,,,,,,,
212,200,G,W,,,,,,,,,,S,,,COSMIC,,,"hg38,12:131909169-131909169","hg38,12:g.131909169G>T",0.496,lung,"carcinoma, adenocarcinoma",,
213,201,K,,,,,,,,,,,S,,,,,,,,,,,,
214,202,A,,,,,,,,,,,S,,,,,,,,,,,,
215,203,D,,,,,,,,,,,S,,,,,,,,,,,,
216,204,L,,,,,,,,,,,S,,,,,,,,,,,,
217,205,W,,,,,,,,,,,S,,,,,,,,,,,,
218,206,S,,,,,,,,,,,S,,,,,,,,,,,,
219,207,I,,,,,,,,,,,S,,,,,,,,,,,,
220,208,G,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,12:132393738-132393738, hg38,12:131909193-131909193","hg19,12:g.132393738G>A, hg38,12:g.131909193G>A",0.867,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000041298081291,
221,209,T,,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM",,,,,,,,,,,
222,210,I,,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM",,,,,,,,,,,
223,211,V,F,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM",,COSMIC,,,"hg38,12:131909202-131909202","hg38,12:g.131909202G>T",0.280,liver,"other, neoplasm",,
224,211,V,I,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM",,cBioPortal,"ucec_cptac_2020, ucec_tcga_pan_can_atlas_2018",Endometrial Carcinoma,"hg19,12:132393747-132393747","hg19,12:g.132393747G>A",0.040,,,,
225,212,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM|Y-based sorting signal, 212-215, ELM",,,,,,,,,,,
226,213,Q,H,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM|Y-based sorting signal, 212-215, ELM",,"cBioPortal,COSMIC",luad_tcga_pan_can_atlas_2018,Lung Adenocarcinoma,"hg19,12:132393755-132393755, hg38,12:131909210-131909210","hg19,12:g.132393755G>T, hg38,12:g.131909210G>T",0.552,"lung, right_upper_lobe","carcinoma, adenocarcinoma",0.0000000000000000,
227,213,Q,R,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM|Y-based sorting signal, 212-215, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132393754-132393754, hg38,12:131909209-131909209","hg19,12:g.132393754A>G, hg38,12:g.131909209A>G",0.571,large_intestine,"carcinoma, adenocarcinoma",0.0000000000000000,
228,214,C,,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM|Y-based sorting signal, 212-215, ELM",,,,,,,,,,,
229,215,L,P,,,,,,,,,,S,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM|Immunoreceptor tyrosine-based motif, 210-215, ELM|Y-based sorting signal, 212-215, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,12:132393760-132393760, hg38,12:131909215-131909215","hg19,12:g.132393760T>C, hg38,12:g.131909215T>C",0.716,breast,carcinoma,,
230,216,T,,,,,,,,,,,C,"Atg8 protein family ligands, 209-220, ELM|Phosphotyrosine ligands bound by SH2 domains, 212-216, ELM",,,,,,,,,,,
231,217,G,,,,,,,,,,,C,"Atg8 protein family ligands, 209-220, ELM",,,,,,,,,,,
232,218,K,,,,,,,,,,,C,"Atg8 protein family ligands, 209-220, ELM",,,,,,,,,,,
233,219,A,V,,,,,,,,,,C,"Atg8 protein family ligands, 209-220, ELM",,cBioPortal,paad_cptac_2021,Pancreatic Adenocarcinoma,"hg19,12:132393772-132393772","hg19,12:g.132393772C>T",0.334,,,,
234,220,P,,,,,,,,,,,C,"Atg8 protein family ligands, 209-220, ELM",,,,,,,,,,,
235,221,F,,,,,,,,,,,C,,,,,,,,,,,,
236,222,Q,L,,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,COSMIC,,,"hg38,12:131909236-131909236","hg38,12:g.131909236A>T",0.344,liver,"other, neoplasm",,
237,223,A,,,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,,,,,,,,,,
238,224,S,,,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,,,,,,,,,,
239,225,S,,P,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,,,,,,,,,,
240,226,P,,,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,,,,,,,,,,
241,227,Q,,,,,,,,,,,C,"WW domain ligands, 222-227, ELM",,,,,,,,,,,
242,228,D,,,,,,,,,,,C,,,,,,,,,,,,
243,229,L,M,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,12:132394338-132394338","hg19,12:g.132394338C>A",0.336,,,,
244,230,R,C,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132394341-132394341","hg19,12:g.132394341C>T",0.531,,,0.0000041409582177,
245,231,L,V,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132394344-132394344","hg19,12:g.132394344C>G",0.200,,,,0.0000319366377108
246,232,F,L,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,COSMIC,,,"hg38,12:131909802-131909802","hg38,12:g.131909802T>C",0.235,stomach,carcinoma,0.0000041133981605,
247,233,Y,,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,,,,,,,,,,
248,234,E,K,,,,,,,,,,C,"APCC activator-binding ABBA motif, 229-234, ELM",,COSMIC,,,"hg38,12:131909808-131909808","hg38,12:g.131909808G>A",0.393,breast,"carcinoma, ductal_carcinoma",0.0000041059330733,
249,235,K,,,,Ubq,,,,,,,C,,,,,,,,,,,,
250,236,N,,,,,,,,,,,C,,,,,,,,,,,,
251,237,K,,,,Ubq,,,,,,,C,,,,,,,,,,,,
252,238,T,K,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,12:132394366-132394366","hg19,12:g.132394366C>A",0.176,,,,
253,239,L,,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,,,,,,,,,,
254,240,V,,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,,,,,,,,,,
255,241,P,,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,,,,,,,,,,
256,242,T,I,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132394378-132394378","hg19,12:g.132394378C>T",0.102,,,0.0020299582548907,0.0015321756894791
257,243,I,,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,,,,,,,,,,
258,244,P,L,,,,,,,,,,C,"SH3 ligand, 238-244, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132394469-132394469","hg19,12:g.132394469C>T",0.570,,,,
259,245,R,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,12:132394472-132394472, hg38,12:131909927-131909927","hg19,12:g.132394472G>T, hg38,12:g.131909927G>T",0.181,lung,"carcinoma, squamous_cell_carcinoma",,
260,246,E,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132394476-132394476, hg38,12:131909931-131909931","hg19,12:g.132394476G>T, hg38,12:g.131909931G>T",0.187,"large_intestine, caecum","carcinoma, adenocarcinoma",,
261,247,T,,,,,,,,,,,C,,,,,,,,,,,,
262,248,S,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132394481-132394481, hg38,12:131909936-131909936","hg19,12:g.132394481C>T, hg38,12:g.131909936C>T",0.419,large_intestine,"carcinoma, adenocarcinoma",0.0000040896115687,
263,249,A,,,,,,,,,,,C,,,,,,,,,,,,
264,250,P,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,12:132394487-132394487, hg38,12:131909942-131909942","hg19,12:g.132394487C>T, hg38,12:g.131909942C>T",0.124,stomach,"carcinoma, adenocarcinoma",0.0000040867369041,
265,250,P,S,,,,,,,,,,C,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132394486-132394486, hg38,12:131909941-131909941","hg19,12:g.132394486C>T, hg38,12:g.131909941C>T",0.082,", large_intestine, colon, ascending","carcinoma, adenocarcinoma, malignant_melanoma",,
266,251,L,,,,,,,,,,,C,"APCC-binding Destruction motifs, 251-259, ELM",,,,,,,,,,,
267,252,R,L,,,,,,,,,,C,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132394493-132394493, hg38,12:131909948-131909948","hg19,12:g.132394493G>T, hg38,12:g.131909948G>T",0.310,lung,"carcinoma, squamous_cell_carcinoma",,
268,252,R,Q,,,,,,,,,,C,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM",,COSMIC,,,"hg38,12:131909948-131909948","hg38,12:g.131909948G>A",0.203,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000286497769410,
269,252,R,W,,,,,,,,,,C,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132394492-132394492, hg38,12:131909947-131909947","hg19,12:g.132394492C>T, hg38,12:g.131909947C>T",0.321,stomach,"carcinoma, adenocarcinoma",,
270,253,Q,,,,,,,,,,,C,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM",,,,,,,,,,,
271,254,L,,,,,,,,,,,C,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM",,,,,,,,,,,
272,255,L,,,,,,,,,,,S,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
273,256,L,,,,,,,,,,,S,"PCSK cleavage site, 252-256, ELM|APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
274,257,A,,,,,,,,,,,C,"APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
275,258,L,,,,,,,,,,,S,"APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
276,259,L,,,,,,,,,,,C,"APCC-binding Destruction motifs, 251-259, ELM|Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
277,260,Q,,,,,,,,,,,S,"Nuclear receptor box, 254-260, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
278,261,R,C,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132394519-132394519, hg38,12:131909974-131909974","hg19,12:g.132394519C>T, hg38,12:g.131909974C>T",0.391,stomach,"carcinoma, adenocarcinoma",,
279,261,R,H,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, paad_tcga, paad_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma","hg19,12:132394520-132394520, hg38,12:131909975-131909975","hg19,12:g.132394520G>A, hg38,12:g.131909975G>A",0.345,"large_intestine, colon, transverse, stomach","carcinoma, carcinoma, adenocarcinoma",0.0000040861357414,
280,262,N,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
281,263,H,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
282,264,K,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Binding motif for UBA3 adenylation domain, 255-264, ELM",,,,,,,,,,,
283,265,D,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM",,,,,,,,,,,
284,266,R,C,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132394534-132394534","hg19,12:g.132394534C>T",0.819,,,,
285,267,M,T,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM",,COSMIC,,,"hg38,12:131909993-131909993","hg38,12:g.131909993T>C",0.275,breast,"carcinoma, ductal_carcinoma",,
286,268,D,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Atg8 protein family ligands, 268-277, ELM",,,,,,,,,,,
287,269,F,,,,,,,,,,,C,"MAPK docking motifs, 261-269, ELM|Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 269-273, ELM",,,,,,,,,,,
288,270,D,,,,,,,,,,,C,"Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 269-273, ELM",,,,,,,,,,,
289,271,E,,,,,,,,,,,C,"Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 269-273, ELM",,,,,,,,,,,
290,272,F,,,,,,,,,,,C,"Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 269-273, ELM",,,,,,,,,,,
291,273,F,V,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 273-276, ELM|Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 269-273, ELM|Pex14 ligand motif, 273-277, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,12:132394807-132394807, hg38,12:131910262-131910262","hg19,12:g.132394807T>G, hg38,12:g.131910262T>G",0.370,endometrium,"carcinoma, endometrioid_carcinoma",,
292,274,H,N,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 273-276, ELM|Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 273-277, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,12:132394810-132394810","hg19,12:g.132394810C>A",0.125,,,,
293,275,H,Y,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 273-276, ELM|Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 273-277, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132394813-132394813, hg38,12:131910268-131910268","hg19,12:g.132394813C>T, hg38,12:g.131910268C>T",0.624,skin,"carcinoma, basal_cell_carcinoma",,
294,276,P,,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 273-276, ELM|Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 273-277, ELM",,,,,,,,,,,
295,277,F,,,,,,,,,,,C,"Atg8 protein family ligands, 268-277, ELM|Pex14 ligand motif, 273-277, ELM",,,,,,,,,,,
296,278,L,,,,,,,,,,,C,"WW domain ligands, 278-283, ELM",,,,,,,,,,,
297,279,D,N,,,,,,,,,,C,"WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, prostate_dkfz_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Prostate","hg19,12:132394825-132394825, hg38,12:131910280-131910280","hg19,12:g.132394825G>A, hg38,12:g.131910280G>A",0.152,"endometrium, large_intestine","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,
298,280,A,,,,,,,,,,,C,"USP7 binding motif, 280-284, ELM|WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,,,,,,,,,,
299,281,S,,P,,,,,,,,,C,"USP7 binding motif, 280-284, ELM|WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,,,,,,,,,,
300,282,P,H,,,,,,,,,,C,"USP7 binding motif, 280-284, ELM|WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132394835-132394835, hg38,12:131910290-131910290","hg19,12:g.132394835C>A, hg38,12:g.131910290C>A",0.105,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",,
301,282,P,R,,,,,,,,,,C,"USP7 binding motif, 280-284, ELM|WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,COSMIC,,,"hg38,12:131910290-131910290","hg38,12:g.131910290C>G",0.047,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
302,283,S,L,,,,,,,,,,C,"USP7 binding motif, 280-284, ELM|WW domain ligands, 278-283, ELM|IAP-binding motif (IBM), 279-283, ELM",,COSMIC,,,"hg38,12:131910293-131910293","hg38,12:g.131910293C>T",0.104,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000119446722780,
303,284,V,I,,,,,,,,,,S,"NRD cleavage site, 284-286, ELM|USP7 binding motif, 280-284, ELM|WW domain ligands, 284-289, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132394840-132394840","hg19,12:g.132394840G>A",0.028,,,,
304,285,R,,,,,,,,,,,S,"NRD cleavage site, 284-286, ELM|MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM",,,,,,,,,,,
305,286,K,,,,,,,,,,,S,"NRD cleavage site, 284-286, ELM|MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM",,,,,,,,,,,
306,287,S,,,,,,,,,,,S,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM",,,,,,,,,,,
307,288,P,,,,,,,,,,,S,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM",,,,,,,,,,,
308,289,P,S,,,,,,,,,,S,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM",,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132395262-132395262","hg19,12:g.132395262C>T",0.043,,,0.0004832963205573,0.0004791719907999
309,289,P,T,,,,,,,,,,S,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|WW domain ligands, 284-289, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM",,COSMIC,,,"hg38,12:131910717-131910717","hg38,12:g.131910717C>A",0.031,ovary,"carcinoma, mixed_adenosquamous_carcinoma",,
310,290,V,M,,,,,,,,,,S,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM|SH3 ligand, 290-296, ELM",,COSMIC,,,"hg38,12:131910720-131910720","hg38,12:g.131910720G>A",0.260,ovary,"carcinoma, mucinous_carcinoma",0.0000319621568063,0.0000957976753097
311,291,P,R,,,,,,,,,,d,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|USP7 binding motif, 291-295, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 285-291, ELM|SH3 ligand, 287-293, ELM|SH3 ligand, 290-296, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132395269-132395269, hg38,12:131910724-131910724","hg19,12:g.132395269C>G, hg38,12:g.131910724C>G",0.159,endometrium,"carcinoma, endometrioid_carcinoma",,
312,292,V,,,,,,,,,,,d,"MAPK docking motifs, 285-292, ELM|MAPK docking motifs, 285-292, ELM|USP7 binding motif, 291-295, ELM|SH3 ligand, 287-293, ELM|SH3 ligand, 290-296, ELM",,,,,,,,,,,
313,293,P,L,,,,,,,,,,d,"USP7 binding motif, 291-295, ELM|SH3 ligand, 287-293, ELM|SH3 ligand, 290-296, ELM",,COSMIC,,,"hg38,12:131910730-131910730","hg38,12:g.131910730C>T",0.066,"skin, upper_arm",malignant_melanoma,,0.0000318999617200
314,293,P,S,,,,,,,,,,d,"USP7 binding motif, 291-295, ELM|SH3 ligand, 287-293, ELM|SH3 ligand, 290-296, ELM",,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,12:132395274-132395274, hg38,12:131910729-131910729","hg19,12:g.132395274C>T, hg38,12:g.131910729C>T",0.087,skin,malignant_melanoma,,
315,294,S,L,,,,,,,,,,d,"USP7 binding motif, 291-295, ELM|SH3 ligand, 290-296, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132395278-132395278, hg38,12:131910733-131910733","hg19,12:g.132395278C>T, hg38,12:g.131910733C>T",0.095,skin,malignant_melanoma,0.0000079920079920,
316,295,Y,,,,,,,,,,,d,"USP7 binding motif, 291-295, ELM|SH3 ligand, 290-296, ELM",,,,,,,,,,,
317,296,P,,,,,,,,,,,d,"SH3 ligand, 290-296, ELM",,,,,,,,,,,
318,297,S,,,,,,,,,,,d,,,,,,,,,,,,
319,298,S,L,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, metastatic_solid_tumors_mich_2017",Mixed Cancer Types,"hg19,12:132395290-132395290, hg38,12:131910745-131910745","hg19,12:g.132395290C>T, hg38,12:g.131910745C>T",0.161,large_intestine,"carcinoma, adenocarcinoma",0.0000079994240415,
320,299,G,,,,,,,,,,,d,,,,,,,,,,,,
321,300,S,,,,,,,,,,,d,,,,,,,,,,,,
322,301,G,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132395298-132395298, hg38,12:131910753-131910753","hg19,12:g.132395298G>A, hg38,12:g.131910753G>A",0.111,"haematopoietic_and_lymphoid_tissue, central_nervous_system","lymphoid_neoplasm, primary_central_nervous_system_lymphoma",0.0000280073939520,0.0000319203268641
323,302,S,,,,,,,,,,,d,,,,,,,,,,,,
324,303,S,,,,,,,,,,,d,,,,,,,,,,,,
325,304,S,,,,,,,,,,,d,,,,,,,,,,,,
326,305,S,N,,,,,,,,,,d,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132395311-132395311, hg38,12:131910766-131910766","hg19,12:g.132395311G>A, hg38,12:g.131910766G>A",0.150,endometrium,"carcinoma, endometrioid_carcinoma",,
327,306,S,N,,,,,,,,,,d,,,cBioPortal,paad_cptac_2021,Pancreatic Adenocarcinoma,"hg19,12:132395314-132395314","hg19,12:g.132395314G>A",0.142,,,,
328,307,S,,,,,,,,,,,d,"FHA phosphopeptide ligands, 307-313, ELM",,,,,,,,,,,
329,308,S,,,,,,,,,,,d,"FHA phosphopeptide ligands, 307-313, ELM",,,,,,,,,,,
330,309,T,,,,,,,,,,,d,"FHA phosphopeptide ligands, 307-313, ELM",,,,,,,,,,,
331,310,S,F,,,,,,,,,,d,"FHA phosphopeptide ligands, 307-313, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132395326-132395326, hg38,12:131910781-131910781","hg19,12:g.132395326C>T, hg38,12:g.131910781C>T",0.193,skin,malignant_melanoma,,
332,311,H,P,,,,,,,,,,d,"WW domain ligands, 311-316, ELM|FHA phosphopeptide ligands, 307-313, ELM",,cBioPortal,acc_2019,Adrenocortical Carcinoma,"hg19,12:132395329-132395329","hg19,12:g.132395329A>C",0.147,,,0.0000623130608175,
333,312,L,P,,,,,,,,,,d,"WW domain ligands, 311-316, ELM|FHA phosphopeptide ligands, 307-313, ELM",,"cBioPortal,COSMIC","stad_tcga_pan_can_atlas_2018, stad_tcga_pub",Stomach Adenocarcinoma,"hg19,12:132395332-132395332, hg38,12:131910787-131910787","hg19,12:g.132395332T>C, hg38,12:g.131910787T>C",0.176,stomach,"carcinoma, adenocarcinoma",0.0000081236088320,
334,313,A,,,,,,,,,,,d,"WW domain ligands, 311-316, ELM|FHA phosphopeptide ligands, 307-313, ELM",,,,,,,,,,,
335,314,S,F,,,,,,,,,,d,"WW domain ligands, 311-316, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132395338-132395338","hg19,12:g.132395338C>T",0.359,,,,
336,315,P,T,,,,,,,,,,d,"WW domain ligands, 311-316, ELM|CtBP ligand motif, 315-319, ELM",,COSMIC,,,"hg38,12:131910795-131910795","hg38,12:g.131910795C>A",0.148,"upper_aerodigestive_tract, mouth",carcinoma,,
337,316,P,,,,,,,,,,,d,"WW domain ligands, 311-316, ELM|CtBP ligand motif, 315-319, ELM",,,,,,,,,,,
338,317,S,F,P,,,,,,,,,d,"CtBP ligand motif, 315-319, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132396488-132396488, hg19,12:132396488-132396489, hg38,12:131911943-131911943","hg19,12:g.132396488C>T, hg19,12:g.132396488_132396489delinsTT, hg38,12:g.131911943C>T",0.140,"large_intestine, colon, left, skin","carcinoma, adenocarcinoma, malignant_melanoma",,
339,318,L,M,,,,,,,,,,d,"CtBP ligand motif, 315-319, ELM",,COSMIC,,,"hg38,12:131911945-131911945","hg38,12:g.131911945C>A",0.109,lung,"carcinoma, squamous_cell_carcinoma",,
340,319,G,,,,,,,,,,,d,"CtBP ligand motif, 315-319, ELM",,,,,,,,,,,
341,320,E,K,,,,,,,,,,d,,,"cBioPortal,COSMIC","cellline_ccle_broad, pancan_pcawg_2020, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,12:132396496-132396496, hg38,12:131911951-131911951","hg19,12:g.132396496G>A, hg38,12:g.131911951G>A",0.080,"stomach, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, adenocarcinoma",0.0000841366378999,0.0001593371574251
342,321,M,,,,,,,,,,,d,,,,,,,,,,,,
343,322,Q,,,,,,,,,,,d,,,,,,,,,,,,
344,323,Q,,,,,,,,,,,d,,,,,,,,,,,,
345,324,L,,,,,,,,,,,d,,,,,,,,,,,,
346,325,Q,L,,,,,,,,,,d,,,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,12:132396512-132396512","hg19,12:g.132396512A>T",0.061,,,,
347,326,K,,,,,,,,,,,d,,,,,,,,,,,,
348,327,T,,,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,,,,,,,,,,
349,328,L,,,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,,,,,,,,,,
350,329,A,T,,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,COSMIC,,,"hg38,12:131911978-131911978","hg38,12:g.131911978G>A",0.071,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,
351,330,S,A,P,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132396526-132396526","hg19,12:g.132396526T>G",0.203,,,0.0004803573858951,0.0003188978888960
352,330,S,F,P,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,12:132396527-132396527, hg38,12:131911982-131911982","hg19,12:g.132396527C>T, hg38,12:g.131911982C>T",0.442,breast,carcinoma,,
353,331,P,L,,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,"cBioPortal,COSMIC","paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,12:132396530-132396530, hg38,12:131911985-131911985","hg19,12:g.132396530C>T, hg38,12:g.131911985C>T",0.299,pancreas,"carcinoma, ductal_carcinoma",0.0000080080721367,
354,332,A,T,,,,,,,,,,d,"WW domain ligands, 327-332, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132396532-132396532","hg19,12:g.132396532G>A",0.058,,,0.0000160149900307,0.0000318674314850
355,333,D,H,,,,,,,,,,d,,,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132396535-132396535, hg38,12:131911990-131911990","hg19,12:g.132396535G>C, hg38,12:g.131911990G>C",0.226,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
356,334,T,,,,,,,,,,,d,,,,,,,,,,,,
357,335,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC","blca_cornell_2016, ucec_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Endometrial Carcinoma","hg19,12:132396541-132396541, hg38,12:131911996-131911996","hg19,12:g.132396541G>A, hg38,12:g.131911996G>A",0.061,endometrium,"carcinoma, endometrioid_carcinoma",0.0000120132626420,
358,336,G,,,,,,,,,,,d,,,,,,,,,,,,
359,337,F,,,,,,,,,,,d,,,,,,,,,,,,
360,338,L,,,,,,,,,,,d,,,,,,,,,,,,
361,339,H,,,,,,,,,,,d,,,,,,,,,,,,
362,340,S,,,,,,,,,,,d,"Caspase cleavage motif, 340-344, ELM",,,,,,,,,,,
363,341,S,,,,,,,,,,,d,"Caspase cleavage motif, 340-344, ELM",,,,,,,,,,,
364,342,R,W,,,,,,,,,,d,"Caspase cleavage motif, 340-344, ELM",,COSMIC,,,"hg38,12:131912017-131912017","hg38,12:g.131912017C>T",0.180,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000200436149060,0.0000955596610817
365,343,D,,,,,,,,,,,d,"Caspase cleavage motif, 340-344, ELM",,,,,,,,,,,
366,344,S,,,,,,,,,,,d,"Caspase cleavage motif, 340-344, ELM",,,,,,,,,,,
367,345,G,,,,,,,,,,,d,,,,,,,,,,,,
368,346,G,,,,,,,,,,,d,,,,,,,,,,,,
369,347,S,,,,,,,,,,,d,,,,,,,,,,,,
370,348,K,,,,,,,,,,,d,,,,,,,,,,,,
371,349,D,,,,,,,,,,,d,,,,,,,,,,,,
372,350,S,,,,,,,,,,,d,,,,,,,,,,,,
373,351,S,,,,,,,,,,,d,,,,,,,,,,,,
374,352,C,,,,,,,,,,,d,,,,,,,,,,,,
375,353,D,,,,,,,,,,,d,,,,,,,,,,,,
376,354,T,I,,,,,,,,,,D,"Atg8 protein family ligands, 354-365, ELM",,COSMIC,,,"hg38,12:131912054-131912054","hg38,12:g.131912054C>T",0.262,thyroid,"other, neoplasm",0.0000040184527350,
377,355,D,Y,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|SH3 ligand, 355-361, ELM",,COSMIC,,,"hg38,12:131912056-131912056","hg38,12:g.131912056G>T",0.489,thyroid,"other, neoplasm",,
378,356,D,,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,,,,,,,,,,
379,357,F,,,,,,,,,,,S,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,,,,,,,,,,
380,358,V,,,,,,,,,,,S,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,,,,,,,,,,
381,359,M,L,,,,,,,,,,S,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,COSMIC,,,"hg38,12:131912068-131912068","hg38,12:g.131912068A>T",0.177,breast,"carcinoma, ductal_carcinoma",0.0000040309252586,
382,360,V,,,,,,,,,,,S,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,,,,,,,,,,
383,361,P,L,,,,,,,,,,S,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM|SH3 ligand, 355-361, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, cscc_ucsf_2021","Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma","hg19,12:132396620-132396620, hg38,12:131912075-131912075","hg19,12:g.132396620C>T, hg38,12:g.131912075C>T",0.413,skin,"carcinoma, basal_cell_carcinoma",,
384,362,A,,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM",,,,,,,,,,,
385,363,Q,,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM",,,,,,,,,,,
386,364,F,,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM",,,,,,,,,,,
387,365,P,,,,,,,,,,,C,"Atg8 protein family ligands, 354-365, ELM|Atg8 protein family ligands, 355-365, ELM|Atg8 protein family ligands, 356-365, ELM",,,,,,,,,,,
388,366,G,D,,,,,,,,,,C,,,COSMIC,,,"hg38,12:131913198-131913198","hg38,12:g.131913198G>A",0.106,"central_nervous_system, brain","glioma, gliomatosis_cerebri",,
389,367,D,,,,,,,,,,,s,,,,,,,,,,,,
390,368,L,,,,,,,,,,,s,,,,,,,,,,,,
391,369,V,M,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131913206-131913206","hg38,12:g.131913206G>A",0.140,liver,"other, neoplasm",,
392,370,A,T,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132397754-132397754, hg38,12:131913209-131913209","hg19,12:g.132397754G>A, hg38,12:g.131913209G>A",0.078,lung,"carcinoma, adenocarcinoma",0.0000044651229248,
393,371,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132397757-132397757, hg38,12:131913212-131913212","hg19,12:g.132397757G>A, hg38,12:g.131913212G>A",0.180,"endometrium, lung","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",,
394,372,A,,,,,,,,,,,s,,,,,,,,,,,,
395,373,P,L,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131913219-131913219","hg38,12:g.131913219C>T",0.108,"skin, chest","malignant_melanoma, superficial_spreading",,
396,374,S,,,,,,,,,,,s,,,,,,,,,,,,
397,375,A,,,,,,,,,,,s,,,,,,,,,,,,
398,376,K,,,,,,,,,,,s,,,,,,,,,,,,
399,377,P,,,,,,,,,,,s,,,,,,,,,,,,
400,378,P,Q,,,,,,,,,,s,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132397779-132397779, hg38,12:131913234-131913234","hg19,12:g.132397779C>A, hg38,12:g.131913234C>A",0.107,skin,malignant_melanoma,,
401,379,P,,,,,,,,,,,s,,,,,,,,,,,,
402,380,D,,,,,,,,,,,s,,,,,,,,,,,,
403,381,S,,,,,,,,,,,s,,,,,,,,,,,,
404,382,L,,,,,,,,,,,s,,,,,,,,,,,,
405,383,M,,,,,,,,,,,s,,,,,,,,,,,,
406,384,C,,,,,,,,,,,s,,,,,,,,,,,,
407,385,S,N,,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, cscc_ucsf_2021","Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,12:132397800-132397800","hg19,12:g.132397800G>A",0.173,,,,
408,386,G,,,,,,,,,,,s,,,,,,,,,,,,
409,387,S,,,,,,,,,,,s,,,,,,,,,,,,
410,388,S,,,,,,,,,,,s,,,,,,,,,,,,
411,389,L,,,,,,,,,,,s,,,,,,,,,,,,
412,390,V,,,,,,,,,,,s,,,,,,,,,,,,
413,391,A,,,,,,,,,,,s,,,,,,,,,,,,
414,392,S,Y,,,,,,,,,,s,,,cBioPortal,hcc_meric_2021,Hepatocellular Carcinoma,"hg19,12:132398309-132398309","hg19,12:g.132398309C>A",0.306,,,,
415,393,A,E,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131913767-131913767","hg38,12:g.131913767C>A",0.149,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, chronic_myelomonocytic_leukaemia",,
416,394,G,,,,,,,,,,,d,,,,,,,,,,,,
417,395,L,,,,,,,,,,,d,,,,,,,,,,,,
418,396,E,,,,,,,,,,,d,,,,,,,,,,,,
419,397,S,,,,,,,,,,,d,,,,,,,,,,,,
420,398,H,,,,,,,,,,,d,"WW domain ligands, 398-403, ELM",,,,,,,,,,,
421,399,G,C,,,,,,,,,,d,"WW domain ligands, 398-403, ELM",,COSMIC,,,"hg38,12:131913784-131913784","hg38,12:g.131913784G>T",0.286,liver,"other, neoplasm",,
422,399,G,S,,,,,,,,,,d,"WW domain ligands, 398-403, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132398329-132398329","hg19,12:g.132398329G>A",0.148,,,0.0000180471210330,0.0000320595024365
423,400,R,P,,,,,,,,,,d,"WW domain ligands, 398-403, ELM|WW domain ligands, 400-405, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132398333-132398333, hg38,12:131913788-131913788","hg19,12:g.132398333G>C, hg38,12:g.131913788G>C",0.247,"skin, head_neck","carcinoma, squamous_cell_carcinoma",0.0000090790238234,
424,400,R,W,,,,,,,,,,d,"WW domain ligands, 398-403, ELM|WW domain ligands, 400-405, ELM",,cBioPortal,acyc_mgh_2016,Adenoid Cystic Carcinoma,"hg19,12:132398332-132398332","hg19,12:g.132398332C>T",0.199,,,0.0001122435235487,
425,401,T,,,,,,,,,,,d,"WW domain ligands, 398-403, ELM|WW domain ligands, 400-405, ELM|SH3 ligand, 401-407, ELM",,,,,,,,,,,
426,402,P,Q,,,,,,,,,,d,"WW domain ligands, 398-403, ELM|WW domain ligands, 400-405, ELM|WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132398339-132398339, hg38,12:131913794-131913794","hg19,12:g.132398339C>A, hg38,12:g.131913794C>A",0.181,skin,malignant_melanoma,,
427,403,S,F,P,,,,,,,,,d,"WW domain ligands, 398-403, ELM|WW domain ligands, 400-405, ELM|WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,12:132398342-132398342, hg38,12:131913797-131913797","hg19,12:g.132398342C>T, hg38,12:g.131913797C>T",0.235,skin,malignant_melanoma,0.0000044947052372,
428,404,P,S,,,,,,,,,,d,"WW domain ligands, 400-405, ELM|WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, ccle_broad_2019, desm_broad_2015","Basal Cell Carcinoma, Desmoplastic Melanoma, Mixed Cancer Types","hg19,12:132398344-132398344, hg38,12:131913799-131913799","hg19,12:g.132398344C>T, hg38,12:g.131913799C>T",0.119,", skin, skin, scalp","carcinoma, basal_cell_carcinoma, malignant_melanoma, malignant_melanoma, desmoplastic",,
429,405,S,F,P,,,,,,,,,d,"WW domain ligands, 400-405, ELM|WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132398348-132398349, hg38,12:131913803-131913804","hg19,12:g.132398348_132398349delinsTT, hg38,12:g.131913803_131913804delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,
430,406,P,Q,,,,,,,,,,d,"WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132398351-132398351","hg19,12:g.132398351C>A",0.256,,,,
431,407,P,,,,,,,,,,,d,"SPOP SBC docking motif, 407-411, ELM|USP7 binding motif, 407-411, ELM|WW domain ligands, 402-407, ELM|SH3 ligand, 401-407, ELM",,,,,,,,,,,
432,408,C,,,,,,,,,,,d,"SPOP SBC docking motif, 407-411, ELM|USP7 binding motif, 407-411, ELM|WW domain ligands, 408-413, ELM",,,,,,,,,,,
433,409,S,,P,,,,,,,,,d,"SPOP SBC docking motif, 407-411, ELM|USP7 binding motif, 407-411, ELM|WW domain ligands, 408-413, ELM",,,,,,,,,,,
434,410,S,,,,,,,,,,,d,"SPOP SBC docking motif, 407-411, ELM|USP7 binding motif, 407-411, ELM|WW domain ligands, 408-413, ELM|WW domain ligands, 410-415, ELM",,,,,,,,,,,
435,411,S,F,,,,,,,,,,d,"SPOP SBC docking motif, 407-411, ELM|USP7 binding motif, 407-411, ELM|WW domain ligands, 408-413, ELM|WW domain ligands, 410-415, ELM",,cBioPortal,"mel_ucla_2016, mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Melanoma, Mixed Cancer Types","hg19,12:132398366-132398366","hg19,12:g.132398366C>T",0.102,,,,
436,412,P,H,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 408-413, ELM|WW domain ligands, 410-415, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132398369-132398369, hg38,12:131913824-131913824","hg19,12:g.132398369C>A, hg38,12:g.131913824C>A",0.261,skin,malignant_melanoma,0.0000049659336949,
437,412,P,L,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 408-413, ELM|WW domain ligands, 410-415, ELM",,cBioPortal,"difg_glass_2019, mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Diffuse Glioma, Mixed Cancer Types","hg19,12:132398369-132398369","hg19,12:g.132398369C>T",0.147,,,,
438,413,S,,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 408-413, ELM|WW domain ligands, 410-415, ELM",,,,,,,,,,,
439,414,P,L,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 410-415, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132398375-132398375, hg38,12:131913830-131913830","hg19,12:g.132398375C>T, hg38,12:g.131913830C>T",0.357,"skin, trunk",malignant_melanoma,0.0000052439484835,
440,414,P,S,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 410-415, ELM",,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132398374-132398374, hg38,12:131913829-131913829","hg19,12:g.132398374C>T, hg38,12:g.131913829C>T",0.311,skin,malignant_melanoma,,
441,415,S,,P,,,,,,,,,d,"USP7 binding motif, 412-416, ELM|WW domain ligands, 410-415, ELM",,,,,,,,,,,
442,416,G,C,,,,,,,,,,d,"USP7 binding motif, 412-416, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132398380-132398380, hg38,12:131913835-131913835","hg19,12:g.132398380G>T, hg38,12:g.131913835G>T",0.273,skin,malignant_melanoma,,
443,417,R,Q,,,,,,,,,,d,,,cBioPortal,egc_tmucih_2015,Esophagogastric Adenocarcinoma,"hg19,12:132398899-132398899","hg19,12:g.132398899G>A",0.117,,,0.0000161915787599,
444,417,R,W,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131914353-131914353","hg38,12:g.131914353C>T",0.226,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia, malignant_melanoma",0.0000162033848871,
445,418,A,,,,,,,,,,,d,,,,,,,,,,,,
446,419,G,,,,,,,,,,,d,,,,,,,,,,,,
447,420,P,,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,,,,,,,,,,
448,421,F,,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,,,,,,,,,,
449,422,S,F,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132398914-132398914, hg38,12:131914369-131914369","hg19,12:g.132398914C>T, hg38,12:g.131914369C>T",0.188,skin,"carcinoma, basal_cell_carcinoma",,
450,422,S,Y,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132398914-132398914, hg38,12:131914369-131914369","hg19,12:g.132398914C>A, hg38,12:g.131914369C>A",0.200,skin,malignant_melanoma,,
451,423,S,,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,,,,,,,,,,
452,424,S,,,,,,,,,,,d,"SPOP SBC docking motif, 420-424, ELM|USP7 binding motif, 420-424, ELM",,,,,,,,,,,
453,425,R,,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM",,,,,,,,,,,
454,426,C,R,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132398925-132398925","hg19,12:g.132398925T>C",0.074,,,,
455,427,G,D,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132398929-132398929, hg38,12:131914384-131914384","hg19,12:g.132398929G>A, hg38,12:g.131914384G>A",0.226,large_intestine,"carcinoma, adenocarcinoma",,
456,428,A,T,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,12:132398931-132398931, hg38,12:131914386-131914386","hg19,12:g.132398931G>A, hg38,12:g.131914386G>A",0.101,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000280928186729,
457,429,S,,P,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,,,,,,,,,,
458,430,V,,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,,,,,,,,,,
459,431,P,L,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132398941-132398941, hg38,12:131914396-131914396","hg19,12:g.132398941C>T, hg38,12:g.131914396C>T",0.579,skin,malignant_melanoma,,
460,431,P,S,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|14-3-3 binding phosphopeptide motif, 425-431, ELM|SH3 ligand, 427-433, ELM",,cBioPortal,mel_ucla_2016,Melanoma,"hg19,12:132398940-132398940","hg19,12:g.132398940C>T",0.512,,,,
461,432,I,,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|SH3 ligand, 427-433, ELM",,,,,,,,,,,
462,433,P,,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM|SH3 ligand, 427-433, ELM",,,,,,,,,,,
463,434,V,I,,,,,,,,,,d,"MAPK docking motifs, 425-434, ELM",,cBioPortal,prad_eururol_2017,Prostate Adenocarcinoma,"hg19,12:132398949-132398949","hg19,12:g.132398949G>A",0.354,,,0.0000000000000000,
464,435,P,I,,,,,,,,,,d,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,12:132398952-132398953","hg19,12:g.132398952_132398953delinsAT",,,,,
465,435,P,L,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,12:132398953-132398953, hg38,12:131914408-131914408","hg19,12:g.132398953C>T, hg38,12:g.131914408C>T",0.548,"large_intestine, large_intestine, colon","carcinoma, adenocarcinoma",,
466,435,P,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132398952-132398952, hg38,12:131914407-131914407","hg19,12:g.132398952C>T, hg38,12:g.131914407C>T",0.527,skin,malignant_melanoma,,
467,436,T,M,,,,,,,,,,d,,,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,12:132398956-132398957",,,,,,
468,437,Q,L,,,,,,,,,,d,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,12:132398959-132398959","hg19,12:g.132398959A>T",0.569,,,,
469,438,V,,,,,,,,,,,d,,,,,,,,,,,,
470,439,Q,,,,,,,,,,,d,,,,,,,,,,,,
471,440,N,,,,,,,,,,,d,,,,,,,,,,,,
472,441,Y,,,,,,,,,,,d,"Y-based sorting signal, 441-444, ELM",,,,,,,,,,,
473,442,Q,,,,,,,,,,,d,"Y-based sorting signal, 441-444, ELM",,,,,,,,,,,
474,443,R,H,,,,,,,,,,d,"Y-based sorting signal, 441-444, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132398977-132398977","hg19,12:g.132398977G>A",0.605,,,,
475,443,R,L,,,,,,,,,,d,"Y-based sorting signal, 441-444, ELM",,COSMIC,,,"hg38,12:131914432-131914432","hg38,12:g.131914432G>T",0.705,liver,"carcinoma, hepatocellular_carcinoma",0.0000080343871771,
476,444,I,M,,,,,,,,,,d,"Y-based sorting signal, 441-444, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,12:132398981-132398982",,,,,,
477,445,E,,,,,,,,,,,d,,,,,,,,,,,,
478,446,R,,,,,,,,,,,d,,,,,,,,,,,,
479,447,N,,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,,,,,,,,,,
480,448,L,M,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132398991-132398991","hg19,12:g.132398991C>A",0.287,,,,
481,449,Q,,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,,,,,,,,,,
482,450,S,,P,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,,,,,,,,,,
483,451,P,L,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132399001-132399001, hg38,12:131914456-131914456","hg19,12:g.132399001C>T, hg38,12:g.131914456C>T",0.373,skin,"carcinoma, basal_cell_carcinoma",,
484,452,T,I,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,COSMIC,,,"hg38,12:131914459-131914459","hg38,12:g.131914459C>T",0.075,lung,carcinoma,,
485,452,T,S,,,,,,,,,,d,"WW domain ligands, 447-452, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,12:131914459-131914459","hg38,12:g.131914459C>G",0.072,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0086098872226040,0.0088194090677534
486,453,Q,,,,,,,,,,,d,"WW domain ligands, 453-458, ELM",,,,,,,,,,,
487,454,F,,,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|PP4 EVH1-binding docking motifs, 454-457, ELM|WW domain ligands, 453-458, ELM",,,,,,,,,,,
488,455,Q,,,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|PP4 EVH1-binding docking motifs, 454-457, ELM|WW domain ligands, 453-458, ELM",,,,,,,,,,,
489,456,T,,P,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|PP4 EVH1-binding docking motifs, 454-457, ELM|WW domain ligands, 453-458, ELM",,,,,,,,,,,
490,457,P,,,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|PP4 EVH1-binding docking motifs, 454-457, ELM|USP7 binding motif, 457-461, ELM|WW domain ligands, 453-458, ELM",,,,,,,,,,,
491,458,R,G,,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|USP7 binding motif, 457-461, ELM|WW domain ligands, 453-458, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,12:132399021-132399021, hg38,12:131914476-131914476","hg19,12:g.132399021C>G, hg38,12:g.131914476C>G",0.259,lung,"carcinoma, adenocarcinoma",,
492,459,S,P,P,,,,,,,,,d,"Cks1 ligand, 454-459, ELM|USP7 binding motif, 457-461, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132399629-132399629","hg19,12:g.132399629T>C",0.264,,,,
493,460,S,C,P,,,,,,,,,d,"USP7 binding motif, 457-461, ELM",,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,12:132399633-132399633, hg38,12:131915088-131915088","hg19,12:g.132399633C>G, hg38,12:g.131915088C>G",0.125,cervix,"carcinoma, squamous_cell_carcinoma",,
494,461,A,,,,,,,,,,,d,"USP7 binding motif, 457-461, ELM",,,,,,,,,,,
495,462,I,,,,,,,,,,,d,"di Arginine retention/retrieving signal, 462-464, ELM",,,,,,,,,,,
496,463,R,C,,,,,,,,,,d,"NRD cleavage site, 463-465, ELM|di Arginine retention/retrieving signal, 462-464, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132399641-132399641, hg38,12:131915096-131915096","hg19,12:g.132399641C>T, hg38,12:g.131915096C>T",0.199,"large_intestine, large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000297220983801,
497,463,R,L,,,,,,,,,,d,"NRD cleavage site, 463-465, ELM|di Arginine retention/retrieving signal, 462-464, ELM",,"cBioPortal,COSMIC",sclc_clcgp,Small Cell Lung Cancer,"hg19,12:132399642-132399642, hg38,12:131915097-131915097","hg19,12:g.132399642G>T, hg38,12:g.131915097G>T",0.109,lung,"carcinoma, small_cell_carcinoma",,
498,464,R,,,,,,,,,,,d,"NRD cleavage site, 463-465, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|di Arginine retention/retrieving signal, 462-464, ELM",,,,,,,,,,,
499,465,S,,P,,,,,,,,,d,"NRD cleavage site, 463-465, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM",,,,,,,,,,,
500,466,G,C,,,,,,,,,,d,"WW domain ligands, 466-471, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|FHA phosphopeptide ligands, 466-472, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132399650-132399650, hg38,12:131915105-131915105","hg19,12:g.132399650G>T, hg38,12:g.131915105G>T",0.153,lung,"carcinoma, squamous_cell_carcinoma",,
501,467,S,,P,,,,,,,,,d,"WW domain ligands, 466-471, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
502,468,T,,P,,,,,,,,,d,"WW domain ligands, 466-471, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
503,469,S,,P,,,,,,,,,d,"WW domain ligands, 466-471, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
504,470,P,,,,,,,,,,,d,"WW domain ligands, 466-471, ELM|14-3-3 binding phosphopeptide motif, 464-470, ELM|FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
505,471,L,,,,,,,,,,,d,"WW domain ligands, 466-471, ELM|FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
506,472,G,,,,,,,,,,,d,"FHA phosphopeptide ligands, 466-472, ELM",,,,,,,,,,,
507,473,F,,,,,,,,,,,d,,,,,,,,,,,,
508,474,A,,,,,,,,,,,d,"WW domain ligands, 474-479, ELM",,,,,,,,,,,
509,475,R,,,,,,,,,,,d,"WW domain ligands, 474-479, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,,,,,,,,,,
510,476,A,T,,,,,,,,,,d,"WW domain ligands, 474-479, ELM|WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,12:132399680-132399680","hg19,12:g.132399680G>A",0.052,,,,
511,477,S,,P,,,,,,,,,d,"WW domain ligands, 474-479, ELM|WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,,,,,,,,,,
512,478,P,L,,,,,,,,,,d,"WW domain ligands, 474-479, ELM|WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,COSMIC,,,"hg38,12:131915142-131915142","hg38,12:g.131915142C>T",0.033,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0061362336395141,0.0066280033140017
513,479,S,L,P,,,,,,,,,d,"WW domain ligands, 474-479, ELM|WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,"cBioPortal,COSMIC","blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,12:132399690-132399690, hg38,12:131915145-131915145","hg19,12:g.132399690C>T, hg38,12:g.131915145C>T",0.097,"urinary_tract, bladder",carcinoma,0.0000084483006243,0.0000318471337580
514,480,P,S,,,,,,,,,,d,"WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,COSMIC,,,"hg38,12:131915147-131915147","hg38,12:g.131915147C>T",0.212,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",0.0000084523708900,0.0000318451054073
515,481,P,,,,,,,,,,,d,"WW domain ligands, 476-481, ELM|SH3 ligand, 475-481, ELM|SH3 ligand, 475-481, ELM",,,,,,,,,,,
516,482,A,,,,,,,,,,,d,,,,,,,,,,,,
517,483,H,,,,,,,,,,,d,,,,,,,,,,,,
518,484,A,P,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131915159-131915159","hg38,12:g.131915159G>C",0.008,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia_therapy_related",,
519,484,A,T,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131915159-131915159","hg38,12:g.131915159G>A",0.011,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000043088590141,0.0000637226789014
520,485,E,V,,,,,,,,,,d,,,"cBioPortal,COSMIC",blca_bgi,Bladder Urothelial Carcinoma,"hg19,12:132399708-132399708, hg38,12:131915163-131915163","hg19,12:g.132399708A>T, hg38,12:g.131915163A>T",0.077,"urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma",,
521,486,H,,,,,,,,,,,d,,,,,,,,,,,,
522,487,G,,,,,,,,,,,d,,,,,,,,,,,,
523,488,G,,,,,,,,,,,d,,,,,,,,,,,,
524,489,V,F,,,,,,,,,,d,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,12:132399719-132399719, hg38,12:131915174-131915174","hg19,12:g.132399719G>T, hg38,12:g.131915174G>T",0.026,lung,"carcinoma, adenocarcinoma",,
525,489,V,I,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132399719-132399719","hg19,12:g.132399719G>A",0.020,,,0.0000579054270748,
526,490,L,,,,,,,,,,,d,,,,,,,,,,,,
527,491,A,T,,,,,,,,,,d,"NRD cleavage site, 491-493, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132399725-132399725","hg19,12:g.132399725G>A",0.047,,,,
528,492,R,K,,,,,,,,,,d,"NRD cleavage site, 491-493, ELM|14-3-3 binding phosphopeptide motif, 492-497, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,12:132399729-132399729","hg19,12:g.132399729G>A",0.125,,,,
529,493,K,,,,,,,,,,,d,"NRD cleavage site, 491-493, ELM|14-3-3 binding phosphopeptide motif, 492-497, ELM",,,,,,,,,,,
530,494,M,,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 492-497, ELM",,,,,,,,,,,
531,495,S,,P,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 492-497, ELM",,,,,,,,,,,
532,496,L,,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 492-497, ELM",,,,,,,,,,,
533,497,G,,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 492-497, ELM",,,,,,,,,,,
534,498,G,,,,,,,,,,,d,"SH3 ligand, 498-504, ELM",,,,,,,,,,,
535,499,G,,,,,,,,,,,d,"SH3 ligand, 498-504, ELM",,,,,,,,,,,
536,500,R,Q,,,,,,,,,,d,"WW domain ligands, 500-505, ELM|SH3 ligand, 498-504, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132399753-132399753","hg19,12:g.132399753G>A",0.118,,,0.0000180720714208,
537,500,R,W,,,,,,,,,,d,"WW domain ligands, 500-505, ELM|SH3 ligand, 498-504, ELM",,"cBioPortal,COSMIC",stad_tcga,Stomach Adenocarcinoma,"hg19,12:132399752-132399752, hg38,12:131915207-131915207","hg19,12:g.132399752C>T, hg38,12:g.131915207C>T",0.182,"large_intestine, stomach","carcinoma, adenocarcinoma",0.0000363811654706,
538,501,P,H,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|SH3 ligand, 498-504, ELM",,COSMIC,,,"hg38,12:131915211-131915211","hg38,12:g.131915211C>A",0.253,"upper_aerodigestive_tract, mouth",carcinoma,,
539,501,P,L,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|SH3 ligand, 498-504, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132399756-132399756, hg38,12:131915211-131915211","hg19,12:g.132399756C>T, hg38,12:g.131915211C>T",0.195,skin,"carcinoma, basal_cell_carcinoma",,
540,502,Y,,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|WW domain ligands, 502-507, ELM|Phosphotyrosine ligands bound by SH2 domains, 502-505, ELM|SH3 ligand, 498-504, ELM",,,,,,,,,,,
541,503,T,,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|WW domain ligands, 502-507, ELM|Phosphotyrosine ligands bound by SH2 domains, 502-505, ELM|SH3 ligand, 498-504, ELM",,,,,,,,,,,
542,504,P,,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|WW domain ligands, 502-507, ELM|Phosphotyrosine ligands bound by SH2 domains, 502-505, ELM|SH3 ligand, 498-504, ELM",,,,,,,,,,,
543,505,S,,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 500-505, ELM|WW domain ligands, 502-507, ELM|Phosphotyrosine ligands bound by SH2 domains, 502-505, ELM",,,,,,,,,,,
544,506,P,,,,,,,,,,,d,"Cks1 ligand, 501-506, ELM|WW domain ligands, 502-507, ELM",,,,,,,,,,,
545,507,Q,E,,,,,,,,,,d,"WW domain ligands, 502-507, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,12:132399773-132399773, hg38,12:131915228-131915228","hg19,12:g.132399773C>G, hg38,12:g.131915228C>G",0.156,"urinary_tract, bladder",carcinoma,,
546,508,V,G,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132399880-132399880, hg38,12:131915335-131915335","hg19,12:g.132399880T>G, hg38,12:g.131915335T>G",0.143,liver,carcinoma,,
547,509,G,,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,,,,,,,,,,
548,510,T,,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,,,,,,,,,,
549,511,I,,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,,,,,,,,,,
550,512,P,,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,,,,,,,,,,
551,513,E,,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,,,,,,,,,,
552,514,R,Q,,,,,,,,,,d,"FHA phosphopeptide ligands, 508-514, ELM|SH3 ligand, 509-515, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132399898-132399898, hg38,12:131915353-131915353","hg19,12:g.132399898G>A, hg38,12:g.131915353G>A",0.024,large_intestine,"carcinoma, adenocarcinoma",0.0002765974504931,0.0001274616021923
553,515,P,,,,,,,,,,,d,"SH3 ligand, 509-515, ELM",,,,,,,,,,,
554,516,G,,,,,,,,,,,d,,,,,,,,,,,,
555,517,W,,,,,,,,,,,d,"WW domain ligands, 517-522, ELM",,,,,,,,,,,
556,518,S,,,,,,,,,,,d,"WW domain ligands, 517-522, ELM",,,,,,,,,,,
557,519,G,R,,,,,,,,,,d,"WW domain ligands, 517-522, ELM|WW domain ligands, 519-524, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132399912-132399912, hg38,12:131915367-131915367","hg19,12:g.132399912G>A, hg38,12:g.131915367G>A",0.002,"large_intestine, colon, ascending, skin, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0000481332327884,0.0000637633105911
558,519,G,W,,,,,,,,,,d,"WW domain ligands, 517-522, ELM|WW domain ligands, 519-524, ELM",,COSMIC,,,"hg38,12:131915367-131915367","hg38,12:g.131915367G>T",0.123,stomach,carcinoma,,
559,520,T,,,,,,,,,,,d,"WW domain ligands, 517-522, ELM|WW domain ligands, 519-524, ELM",,,,,,,,,,,
560,521,P,,,,,,,,,,,d,"WW domain ligands, 517-522, ELM|WW domain ligands, 519-524, ELM",,,,,,,,,,,
561,522,S,,P,,,,,,,,,d,"WW domain ligands, 517-522, ELM|WW domain ligands, 519-524, ELM",,,,,,,,,,,
562,523,P,S,,,,,,,,,,d,"WW domain ligands, 519-524, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,12:132399924-132399924","hg19,12:g.132399924C>T",0.048,,,,
563,524,Q,,,,,,,,,,,d,"WW domain ligands, 519-524, ELM",,,,,,,,,,,
564,525,G,R,,,,,,,,,,d,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132399930-132399930","hg19,12:g.132399930G>A",0.137,,,,
565,526,A,,,,,,,,,,,d,,,,,,,,,,,,
566,527,E,,,,,,,,,,,d,,,,,,,,,,,,
567,528,M,,,,,,,,,,,d,,,,,,,,,,,,
568,529,R,L,,Me,,,,,,,,d,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132399943-132399943, hg38,12:131915398-131915398","hg19,12:g.132399943G>T, hg38,12:g.131915398G>T",0.126,lung,"carcinoma, squamous_cell_carcinoma",,
569,529,R,Q,,Me,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, difg_glass_2019","Diffuse Glioma, Mixed Cancer Types","hg19,12:132399943-132399943, hg38,12:131915398-131915398","hg19,12:g.132399943G>A, hg38,12:g.131915398G>A",0.077,"skin, back","carcinoma, squamous_cell_carcinoma",0.0000201479666672,
570,530,G,S,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coad_cptac_2019","Colon Adenocarcinoma, Mixed Cancer Types","hg19,12:132399945-132399945, hg38,12:131915400-131915400","hg19,12:g.132399945G>A, hg38,12:g.131915400G>A",0.017,stomach,"carcinoma, adenocarcinoma",,
571,531,G,Y,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132399948-132399949, hg38,12:131915403-131915404","hg19,12:g.132399948_132399949delinsTA, hg38,12:g.131915403_131915404delinsTA",,skin,"carcinoma, basal_cell_carcinoma",,
572,532,R,,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,,,,,,,,,,
573,533,S,,P,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,,,,,,,,,,
574,534,P,F,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,12:132399957-132399958","hg19,12:g.132399957_132399958delinsTT",,,,,
575,534,P,L,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,12:132399958-132399958, hg38,12:131915413-131915413","hg19,12:g.132399958C>T, hg38,12:g.131915413C>T",0.198,skin,malignant_melanoma,0.0000324109711137,0.0000318633698700
576,534,P,S,,,,,,,,,,d,"WW domain ligands, 530-535, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,12:132399957-132399957, hg38,12:131915412-131915412","hg19,12:g.132399957C>T, hg38,12:g.131915412C>T",0.124,skin,malignant_melanoma,,
577,535,R,C,,,,,,,,,,d,"WW domain ligands, 530-535, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132399960-132399960","hg19,12:g.132399960C>T",0.126,,,0.0000040558408164,
578,535,R,G,,,,,,,,,,d,"WW domain ligands, 530-535, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,12:132399960-132399960","hg19,12:g.132399960C>G",0.056,,,,
579,535,R,H,,,,,,,,,,d,"WW domain ligands, 530-535, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132399961-132399961","hg19,12:g.132399961G>A",0.142,,,,
580,536,P,A,,,,,,,,,,d,"USP7 binding motif, 536-540, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,12:132399963-132399963, hg38,12:131915418-131915418","hg19,12:g.132399963C>G, hg38,12:g.131915418C>G",0.076,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000203067125869,0.0000637226789014
581,537,G,,,,,,,,,,,d,"USP7 binding motif, 536-540, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,,,,,,,,,,
582,538,S,F,P,,,,,,,,,d,"USP7 binding motif, 536-540, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132400439-132400439, hg38,12:131915894-131915894","hg19,12:g.132400439C>T, hg38,12:g.131915894C>T",0.126,skin,"carcinoma, basal_cell_carcinoma",,
583,539,S,,P,,,,,,,,,d,"USP7 binding motif, 536-540, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,,,,,,,,,,
584,540,A,,,,,,,,,,,d,"USP7 binding motif, 536-540, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,,,,,,,,,,
585,541,P,H,,,,,,,,,,d,"WW domain ligands, 541-546, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,COSMIC,,,"hg38,12:131915903-131915903","hg38,12:g.131915903C>A",0.253,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
586,541,P,S,,,,,,,,,,d,"WW domain ligands, 541-546, ELM|14-3-3 binding phosphopeptide motif, 535-541, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132400447-132400447","hg19,12:g.132400447C>T",0.203,,,0.0000040980247521,
587,542,E,,,,,,,,,,,d,"WW domain ligands, 541-546, ELM",,,,,,,,,,,
588,543,H,,,,,,,,,,,d,"WW domain ligands, 541-546, ELM",,,,,,,,,,,
589,544,S,C,P,,,,,,,,,d,"WW domain ligands, 541-546, ELM",,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,12:132400457-132400457, hg38,12:131915912-131915912","hg19,12:g.132400457C>G, hg38,12:g.131915912C>G",0.269,"cervix, skin, abdomen","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,
590,545,P,S,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|WW domain ligands, 541-546, ELM|FHA phosphopeptide ligands, 545-551, ELM",,cBioPortal,pcpg_tcga_pub,Soft Tissue,"hg19,12:132400459-132400459","hg19,12:g.132400459C>T",0.093,,,,
591,546,R,C,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|WW domain ligands, 541-546, ELM|FHA phosphopeptide ligands, 545-551, ELM",,"cBioPortal,COSMIC","skcm_broad_brafresist_2012, stad_tcga_pan_can_atlas_2018, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Cutaneous Melanoma, Endometrial Carcinoma, Stomach Adenocarcinoma","hg19,12:132400462-132400462, hg38,12:131915917-131915917","hg19,12:g.132400462C>T, hg38,12:g.131915917C>T",0.156,", endometrium, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, malignant_melanoma",0.0001020241593209,0.0001914608462569
592,546,R,H,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|WW domain ligands, 541-546, ELM|FHA phosphopeptide ligands, 545-551, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132400463-132400463","hg19,12:g.132400463G>A",0.058,,,0.0001429096402760,0.0002233995021383
593,547,T,,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|FHA phosphopeptide ligands, 545-551, ELM",,,,,,,,,,,
594,548,S,,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|FHA phosphopeptide ligands, 545-551, ELM",,,,,,,,,,,
595,549,G,R,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|FHA phosphopeptide ligands, 545-551, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub","Colorectal Adenocarcinoma, Renal Clear Cell Carcinoma","hg19,12:132400471-132400471, hg38,12:131915926-131915926","hg19,12:g.132400471G>A, hg38,12:g.131915926G>A",0.289,"kidney, large_intestine","carcinoma, adenocarcinoma, carcinoma, clear_cell_renal_cell_carcinoma",0.0000081484982318,
596,549,G,W,,,,,,,,,,d,"USP7 binding motif, 545-549, ELM|FHA phosphopeptide ligands, 545-551, ELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,12:132400471-132400471","hg19,12:g.132400471G>T",0.340,,,,
597,550,L,,,,,,,,,,,d,"FHA phosphopeptide ligands, 545-551, ELM",,,,,,,,,,,
598,551,G,,,,,,,,,,,d,"FHA phosphopeptide ligands, 545-551, ELM",,,,,,,,,,,
599,552,C,Y,,,,,,,,,,d,,,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132400481-132400481, hg38,12:131915936-131915936","hg19,12:g.132400481G>A, hg38,12:g.131915936G>A",0.080,skin,malignant_melanoma,,
600,553,R,C,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,"cBioPortal,COSMIC",gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132400483-132400483, hg38,12:131915938-131915938","hg19,12:g.132400483C>T, hg38,12:g.131915938C>T",0.336,"large_intestine, caecum","adenoma, villous, carcinoma, adenocarcinoma",0.0001585933179349,0.0000638162093172
601,553,R,H,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,COSMIC,,,"hg38,12:131915939-131915939","hg38,12:g.131915939G>A",0.298,stomach,carcinoma,0.0000121980970969,
602,554,L,Q,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,"cBioPortal,COSMIC",ccrcc_utokyo_2013,Renal Clear Cell Carcinoma,"hg19,12:132400487-132400487, hg38,12:131915942-131915942","hg19,12:g.132400487T>A, hg38,12:g.131915942T>A",0.386,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
603,555,H,,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,,,,,,,,,,
604,556,S,I,P,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132400493-132400493, hg38,12:131915948-131915948","hg19,12:g.132400493G>T, hg38,12:g.131915948G>T",0.319,stomach,"carcinoma, adenocarcinoma",,
605,557,A,T,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,"cBioPortal,COSMIC",difg_glass_2019,Diffuse Glioma,"hg19,12:132400495-132400495, hg38,12:131915950-131915950","hg19,12:g.132400495G>A, hg38,12:g.131915950G>A",0.184,stomach,carcinoma,0.0000203247075275,
606,558,P,S,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 553-558, ELM",,COSMIC,,,"hg38,12:131915953-131915953","hg38,12:g.131915953C>T",0.393,skin,malignant_melanoma,,
607,559,N,K,,,,,,,,,,d,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132400503-132400503","hg19,12:g.132400503C>G",0.046,,,,
608,560,L,,,,,,,,,,,d,,,,,,,,,,,,
609,561,S,,P,,,,,,,,,d,,,,,,,,,,,,
610,562,D,,,,,,,,,,,d,"SH3 ligand, 562-568, ELM",,,,,,,,,,,
611,563,L,,,,,,,,,,,d,"SH3 ligand, 562-568, ELM",,,,,,,,,,,
612,564,H,,,,,,,,,,,d,"SH3 ligand, 562-568, ELM",,,,,,,,,,,
613,565,V,I,,,,,,,,,,d,"SH3 ligand, 562-568, ELM|SH3 ligand, 565-571, ELM",,"cBioPortal,COSMIC","nepc_wcm_2016, prad_p1000, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,12:132400519-132400519, hg38,12:131915974-131915974","hg19,12:g.132400519G>A, hg38,12:g.131915974G>A",0.044,stomach,carcinoma,0.0000081203764607,
614,566,V,I,,,,,,,,,,d,"SH3 ligand, 562-568, ELM|SH3 ligand, 565-571, ELM",,COSMIC,,,"hg38,12:131915977-131915977","hg38,12:g.131915977G>A",0.057,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000162420718387,0.0001278527136738
615,567,R,H,,,,,,,,,,d,"SH3 ligand, 562-568, ELM|SH3 ligand, 565-571, ELM",,"cBioPortal,COSMIC","pancan_pcawg_2020, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_cptac_2020","Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,12:132400526-132400526, hg38,12:131915981-131915981","hg19,12:g.132400526G>A, hg38,12:g.131915981G>A",0.106,"liver, ovary, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, mucinous_carcinoma",0.0000406249746094,
616,567,R,L,,,,,,,,,,d,"SH3 ligand, 562-568, ELM|SH3 ligand, 565-571, ELM",,COSMIC,,,"hg38,12:131915981-131915981","hg38,12:g.131915981G>T",0.092,lung,carcinoma,,
617,568,P,,,,,,,,,,,d,"SH3 ligand, 562-568, ELM|SH3 ligand, 565-571, ELM|SH3 ligand, 568-574, ELM",,,,,,,,,,,
618,569,K,,,,,,,,,,,d,"SH3 ligand, 565-571, ELM|SH3 ligand, 568-574, ELM",,,,,,,,,,,
619,570,L,,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|SH3 ligand, 565-571, ELM|SH3 ligand, 568-574, ELM",,,,,,,,,,,
620,571,P,,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|SH3 ligand, 565-571, ELM|SH3 ligand, 568-574, ELM|SH3 ligand, 571-577, ELM",,,,,,,,,,,
621,572,K,,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|SH3 ligand, 568-574, ELM|SH3 ligand, 571-577, ELM",,,,,,,,,,,
622,573,P,L,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 568-574, ELM|SH3 ligand, 571-577, ELM",,COSMIC,,,"hg38,12:131915999-131915999","hg38,12:g.131915999C>T",0.107,"skin, extremity","malignant_melanoma, nodular",0.0000040704679410,
623,574,P,R,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 568-574, ELM|SH3 ligand, 571-577, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,12:131916002-131916002","hg38,12:g.131916002C>G",0.041,"skin, trunk","malignant_melanoma, nodular",0.0015542860862914,0.0014690853346960
624,574,P,T,,,,,,,,,,d,"EVH1  ligands, 570-574, ELM|FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 568-574, ELM|SH3 ligand, 571-577, ELM",,COSMIC,,,"hg38,12:131916001-131916001","hg38,12:g.131916001C>A",0.077,stomach,carcinoma,,
625,575,T,M,P,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 571-577, ELM",,COSMIC,,,"hg38,12:131916005-131916005","hg38,12:g.131916005C>T",0.146,"large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000244170430961,
626,575,T,P,P,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 571-577, ELM",,COSMIC,,,"hg38,12:131916004-131916004","hg38,12:g.131916004A>C",0.114,thyroid,carcinoma,,
627,576,D,N,,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 571-577, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132400552-132400552","hg19,12:g.132400552G>A",0.141,,,,
628,577,P,H,,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 571-577, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132400556-132400556, hg38,12:131916011-131916011","hg19,12:g.132400556C>A, hg38,12:g.131916011C>A",0.238,skin,malignant_melanoma,,
629,578,L,M,,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 578-584, ELM",,"cBioPortal,COSMIC",lusc_tcga_pan_can_atlas_2018,Lung Squamous Cell Carcinoma,"hg19,12:132400558-132400558, hg38,12:131916013-131916013","hg19,12:g.132400558C>A, hg38,12:g.131916013C>A",0.081,lung,"carcinoma, squamous_cell_carcinoma",,
630,579,G,,,,,,,,,,,d,"FHA phosphopeptide ligands, 573-579, ELM|SH3 ligand, 578-584, ELM",,,,,,,,,,,
631,580,A,,,,,,,,,,,d,"WW domain ligands, 580-585, ELM|SH3 ligand, 578-584, ELM",,,,,,,,,,,
632,581,V,,,,,,,,,,,d,"WW domain ligands, 580-585, ELM|SH3 ligand, 578-584, ELM",,,,,,,,,,,
633,582,F,,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 582-585, ELM|WW domain ligands, 580-585, ELM|SH3 ligand, 578-584, ELM",,,,,,,,,,,
634,583,S,,P,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 582-585, ELM|WW domain ligands, 580-585, ELM|SH3 ligand, 578-584, ELM",,,,,,,,,,,
635,584,P,L,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 582-585, ELM|WW domain ligands, 580-585, ELM|SH3 ligand, 578-584, ELM",,COSMIC,,,"hg38,12:131916032-131916032","hg38,12:g.131916032C>T",0.095,lung,"carcinoma, squamous_cell_carcinoma",,
636,585,P,,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 582-585, ELM|WW domain ligands, 580-585, ELM|WW domain ligands, 585-590, ELM",,,,,,,,,,,
637,586,Q,,,,,,,,,,,d,"WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,,,,,,,,,,
638,587,A,,,,,,,,,,,d,"WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,,,,,,,,,,
639,588,S,,P,,,,,,,,,d,"WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,,,,,,,,,,
640,589,P,H,,,,,,,,,,d,"WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,"cBioPortal,COSMIC",kirc_tcga_pan_can_atlas_2018,Renal Clear Cell Carcinoma,"hg19,12:132400592-132400592, hg38,12:131916047-131916047","hg19,12:g.132400592C>A, hg38,12:g.131916047C>A",0.042,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
641,590,P,H,,,,,,,,,,d,"USP7 binding motif, 590-594, ELM|WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,12:132400595-132400595","hg19,12:g.132400595C>A",0.091,,,0.0000122474974280,
642,590,P,S,,,,,,,,,,d,"USP7 binding motif, 590-594, ELM|WW domain ligands, 585-590, ELM|SH3 ligand, 586-592, ELM",,COSMIC,,,"hg38,12:131916049-131916049","hg38,12:g.131916049C>T",0.036,skin,malignant_melanoma,,
643,591,Q,,,,,,,,,,,d,"USP7 binding motif, 590-594, ELM|SH3 ligand, 586-592, ELM",,,,,,,,,,,
644,592,P,S,,,,,,,,,,d,"USP7 binding motif, 590-594, ELM|SH3 ligand, 586-592, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132400600-132400600","hg19,12:g.132400600C>T",0.022,,,0.0000000000000000,
645,593,S,,P,,,,,,,,,d,"USP7 binding motif, 590-594, ELM",,,,,,,,,,,
646,594,H,,,,,,,,,,,d,"USP7 binding motif, 590-594, ELM",,,,,,,,,,,
647,595,G,R,,,,,,,,,,d,,,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132400609-132400609, hg38,12:131916064-131916064","hg19,12:g.132400609G>C, hg38,12:g.131916064G>C",0.241,lung,"carcinoma, squamous_cell_carcinoma",,
648,595,G,S,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131916064-131916064","hg38,12:g.131916064G>A",0.110,liver,carcinoma,0.0000122541010391,
649,596,L,,,,,,,,,,,d,,,,,,,,,,,,
650,597,Q,,,,,,,,,,,d,,,,,,,,,,,,
651,598,S,P,P,,,,,,,,,d,,,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,12:132400618-132400618, hg38,12:131916073-131916073","hg19,12:g.132400618T>C, hg38,12:g.131916073T>C",0.018,"pancreas, ampulla_of_Vater","carcinoma, ductal_carcinoma",,
652,599,C,,,,,,,,,,,d,,,,,,,,,,,,
653,600,R,,,,,,,,,,,d,,,,,,,,,,,,
654,601,N,,,,,,,,,,,d,,,,,,,,,,,,
655,602,L,P,,,,,,,,,,d,"WW domain ligands, 602-607, ELM",,COSMIC,,,"hg38,12:131916086-131916086","hg38,12:g.131916086T>C",0.066,stomach,"carcinoma, adenocarcinoma",0.0000122629169392,0.0000319815786107
656,603,R,Q,,,,,,,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132400634-132400634","hg19,12:g.132400634G>A",0.113,,,0.0000000000000000,
657,603,R,W,,,,,,,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132400633-132400633, hg38,12:131916088-131916088","hg19,12:g.132400633C>T, hg38,12:g.131916088C>T",0.144,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0002494153051044,0.0000957426437735
658,604,G,C,,,,,,,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132400636-132400636, hg38,12:131916091-131916091","hg19,12:g.132400636G>T, hg38,12:g.131916091G>T",0.014,lung,"carcinoma, adenocarcinoma",,
659,605,S,,P,,,,,,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,,,,,,,,,,
660,606,P,,,,,,,,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,,,,,,,,,,
661,607,K,,,,,,,Ac,,,,d,"WW domain ligands, 602-607, ELM|SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,,,,,,,,,,
662,608,L,,,,,,,,,,,d,"SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,,,,,,,,,,
663,609,P,,,,,,,,,,,s,"SH3 ligand, 603-609, ELM|SH3 ligand, 603-609, ELM",,,,,,,,,,,
664,610,D,,,,,,,,,,,s,,,,,,,,,,,,
665,611,F,,,,,,,,,,,s,,,,,,,,,,,,
666,612,L,,,,,,,,,,,s,,,,,,,,,,,,
667,613,Q,,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,,,,,,,,,,
668,614,R,,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,,,,,,,,,,
669,615,N,Y,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132400669-132400669","hg19,12:g.132400669A>T",0.102,,,,
670,616,P,L,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,cBioPortal,"angs_painter_2020, angs_project_painter_2018",Angiosarcoma,"hg19,12:132400673-132400673","hg19,12:g.132400673C>T",0.285,,,0.0000082183449897,
671,616,P,S,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,cBioPortal,"angs_painter_2020, angs_project_painter_2018",Angiosarcoma,"hg19,12:132400672-132400672","hg19,12:g.132400672C>T",0.265,,,0.0000082218586334,
672,617,L,,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,,,,,,,,,,
673,618,P,S,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132400678-132400678, hg38,12:131916133-131916133","hg19,12:g.132400678C>T, hg38,12:g.131916133C>T",0.318,skin,"carcinoma, basal_cell_carcinoma",0.0000329367203261,0.0000318938572431
674,619,P,L,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,"cBioPortal,COSMIC","brca_igr_2015, cscc_hgsc_bcm_2014","Cutaneous Squamous Cell Carcinoma, Invasive Breast Carcinoma","hg19,12:132400682-132400682, hg38,12:131916137-131916137","hg19,12:g.132400682C>T, hg38,12:g.131916137C>T",0.063,"breast, skin, head_neck","carcinoma, ER-PR-positive_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000082506889325,
675,619,P,S,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|SH3 ligand, 613-619, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,12:132400681-132400681","hg19,12:g.132400681C>T",0.067,,,,
676,620,I,,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|WW domain ligands, 620-625, ELM",,,,,,,,,,,
677,621,L,M,,,,,,,,,,s,"APCC-binding Destruction motifs, 613-621, ELM|WW domain ligands, 620-625, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132400687-132400687","hg19,12:g.132400687C>A",0.064,,,,
678,622,G,V,,,,,,,,,,s,"WW domain ligands, 620-625, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132400691-132400691","hg19,12:g.132400691G>T",0.587,,,,
679,623,S,F,P,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|WW domain ligands, 620-625, ELM|FHA phosphopeptide ligands, 623-629, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132400694-132400694, hg38,12:131916149-131916149","hg19,12:g.132400694C>T, hg38,12:g.131916149C>T",0.261,skin,malignant_melanoma,,
680,624,P,H,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|WW domain ligands, 620-625, ELM|FHA phosphopeptide ligands, 623-629, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132400697-132400697, hg38,12:131916152-131916152","hg19,12:g.132400697C>A, hg38,12:g.131916152C>A",0.550,skin,malignant_melanoma,,
681,624,P,S,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|WW domain ligands, 620-625, ELM|FHA phosphopeptide ligands, 623-629, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132400696-132400696","hg19,12:g.132400696C>T",0.473,,,,
682,625,T,I,P,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|WW domain ligands, 620-625, ELM|FHA phosphopeptide ligands, 623-629, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132400700-132400700, hg38,12:131916155-131916155","hg19,12:g.132400700C>T, hg38,12:g.131916155C>T",0.198,skin,"carcinoma, basal_cell_carcinoma",,
683,626,K,,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|FHA phosphopeptide ligands, 623-629, ELM",,,,,,,,,,,
684,627,A,,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|USP7 binding motif, 627-631, ELM|FHA phosphopeptide ligands, 623-629, ELM",,,,,,,,,,,
685,628,V,,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|USP7 binding motif, 627-631, ELM|FHA phosphopeptide ligands, 623-629, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,,,,,,,,,,
686,629,P,L,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|USP7 binding motif, 627-631, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|FHA phosphopeptide ligands, 623-629, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132400950-132400950, hg38,12:131916405-131916405","hg19,12:g.132400950C>T, hg38,12:g.131916405C>T",0.151,skin,malignant_melanoma,,
687,630,S,F,P,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|USP7 binding motif, 627-631, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132400953-132400953, hg38,12:131916408-131916408","hg19,12:g.132400953C>T, hg38,12:g.131916408C>T",0.097,skin,malignant_melanoma,,
688,630,S,Y,P,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|USP7 binding motif, 627-631, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,COSMIC,,,"hg38,12:131916408-131916408","hg38,12:g.131916408C>A",0.117,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
689,631,F,,,,,,,,,,,s,"COP1 E3 ligase binding degron motif, 623-631, ELM|MAPK docking motifs, 631-634, ELM|PP4 EVH1-binding docking motifs, 631-634, ELM|USP7 binding motif, 627-631, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|SH3 ligand, 631-637, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,,,,,,,,,,
690,632,D,,,,,,,,,,,s,"MAPK docking motifs, 631-634, ELM|PP4 EVH1-binding docking motifs, 631-634, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|SH3 ligand, 631-637, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,,,,,,,,,,
691,633,F,,,,,,,,,,,s,"MAPK docking motifs, 631-634, ELM|PP4 EVH1-binding docking motifs, 631-634, ELM|WW domain ligands, 633-638, ELM|BRCT phosphopeptide ligands, 629-633, ELM|BRCT phosphopeptide ligands, 629-635, ELM|SH3 ligand, 631-637, ELM|WAVE regulatory complex (WRC) binding site motif, 628-633, ELM",,,,,,,,,,,
692,634,P,L,,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|MAPK docking motifs, 631-634, ELM|PP4 EVH1-binding docking motifs, 631-634, ELM|WW domain ligands, 633-638, ELM|BRCT phosphopeptide ligands, 629-635, ELM|SH3 ligand, 631-637, ELM",,COSMIC,,,"hg38,12:131916420-131916420","hg38,12:g.131916420C>T",0.164,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0002024657746685,0.0001274616021923
693,635,K,,,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|WW domain ligands, 633-638, ELM|BRCT phosphopeptide ligands, 629-635, ELM|SH3 ligand, 631-637, ELM",,,,,,,,,,,
694,636,T,A,P,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|WW domain ligands, 633-638, ELM|SH3 ligand, 631-637, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132400970-132400970, hg38,12:131916425-131916425","hg19,12:g.132400970A>G, hg38,12:g.131916425A>G",0.062,lung,"carcinoma, adenocarcinoma",,
695,637,P,S,,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|WW domain ligands, 633-638, ELM|SH3 ligand, 631-637, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132400973-132400973, hg38,12:131916428-131916428","hg19,12:g.132400973C>T, hg38,12:g.131916428C>T",0.071,endometrium,"carcinoma, endometrioid_carcinoma",,
696,637,P,T,,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|WW domain ligands, 633-638, ELM|SH3 ligand, 631-637, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132400973-132400973, hg38,12:131916428-131916428","hg19,12:g.132400973C>A, hg38,12:g.131916428C>A",0.127,"large_intestine, caecum","carcinoma, adenocarcinoma",,
697,638,S,,P,,,,,,,,,s,"Cks1 ligand, 634-639, ELM|WW domain ligands, 633-638, ELM",,,,,,,,,,,
698,639,S,,P,,,,,,,,,s,"Cks1 ligand, 634-639, ELM",,,,,,,,,,,
699,640,Q,K,,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,12:132400982-132400982","hg19,12:g.132400982C>A",0.067,,,,
700,641,N,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
701,642,L,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
702,643,L,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
703,644,A,V,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132400995-132400995, hg38,12:131916450-131916450","hg19,12:g.132400995C>T, hg38,12:g.131916450C>T",0.044,lung,"carcinoma, squamous_cell_carcinoma",0.0000040471410995,0.0000318755578223
704,645,L,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
705,646,L,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
706,647,A,,,,,,,,,,,s,"Nuclear receptor box, 641-647, ELM",,,,,,,,,,,
707,648,R,L,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132401007-132401007, hg38,12:131916462-131916462","hg19,12:g.132401007G>T, hg38,12:g.131916462G>T",0.109,stomach,"carcinoma, adenocarcinoma",,
708,648,R,Q,,,,,,,,,,s,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132401007-132401007","hg19,12:g.132401007G>A",0.078,,,0.0000241279747782,0.0000318877551020
709,649,Q,,,,,,,,,,,s,"SH3 ligand, 649-655, ELM",,,,,,,,,,,
710,650,G,,,,,,,,,,,s,"SH3 ligand, 649-655, ELM",,,,,,,,,,,
711,651,V,M,,,,,,,,,,s,"WW domain ligands, 651-656, ELM|SH3 ligand, 649-655, ELM",,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_cptac_2020","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,12:132401015-132401015, hg38,12:131916470-131916470","hg19,12:g.132401015G>A, hg38,12:g.131916470G>A",0.056,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000441625180665,0.0000318897888896
712,652,V,G,,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|WW domain ligands, 651-656, ELM|SH3 ligand, 649-655, ELM",,COSMIC,,,"hg38,12:131916474-131916474","hg38,12:g.131916474T>G",0.103,"large_intestine, colon, left","carcinoma, adenocarcinoma",,
713,653,M,,,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|PP4 EVH1-binding docking motifs, 653-656, ELM|WW domain ligands, 651-656, ELM|SH3 ligand, 649-655, ELM",,,,,,,,,,,
714,654,T,M,P,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|PP4 EVH1-binding docking motifs, 653-656, ELM|WW domain ligands, 651-656, ELM|SH3 ligand, 649-655, ELM|WW domain ligands, 654-658, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132401025-132401025, hg38,12:131916480-131916480","hg19,12:g.132401025C>T, hg38,12:g.131916480C>T",0.086,large_intestine,"carcinoma, adenocarcinoma",0.0000722508549685,0.0000318958918091
715,655,P,,,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|PP4 EVH1-binding docking motifs, 653-656, ELM|WW domain ligands, 651-656, ELM|SH3 ligand, 649-655, ELM|WW domain ligands, 654-658, ELM",,,,,,,,,,,
716,656,P,,,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|PP4 EVH1-binding docking motifs, 653-656, ELM|WW domain ligands, 651-656, ELM|WW domain ligands, 654-658, ELM|di Arginine retention/retrieving signal, 656-659, ELM",,,,,,,,,,,
717,657,R,Q,,,,,,,,,,s,"Cks1 ligand, 652-657, ELM|14-3-3 binding phosphopeptide motif, 657-662, ELM|WW domain ligands, 654-658, ELM|di Arginine retention/retrieving signal, 656-659, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,12:132401034-132401034, hg38,12:131916489-131916489","hg19,12:g.132401034G>A, hg38,12:g.131916489G>A",0.149,endometrium,"carcinoma, endometrioid_carcinoma",0.0000040150645221,
718,658,N,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM|WW domain ligands, 654-658, ELM|di Arginine retention/retrieving signal, 656-659, ELM",,,,,,,,,,,
719,659,R,Q,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM|di Arginine retention/retrieving signal, 656-659, ELM",,cBioPortal,prad_p1000,Prostate Adenocarcinoma,"hg19,12:132401040-132401040","hg19,12:g.132401040G>A",0.083,,,0.0000200846769982,
720,659,R,W,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM|di Arginine retention/retrieving signal, 656-659, ELM",,COSMIC,,,"hg38,12:131916494-131916494","hg38,12:g.131916494C>T",0.200,"upper_aerodigestive_tract, mouth, tongue","carcinoma, squamous_cell_carcinoma",0.0003212464361723,0.0000637348629700
721,660,T,M,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, stad_oncosg_2018","Colorectal Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132401043-132401043, hg38,12:131916498-131916498","hg19,12:g.132401043C>T, hg38,12:g.131916498C>T",0.214,large_intestine,"carcinoma, adenocarcinoma",0.0001205322705066,0.0001275428862955
722,661,L,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM|14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM",,,,,,,,,,,
723,662,P,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM|14-3-3 binding phosphopeptide motif, 657-662, ELM|FHA phosphopeptide ligands, 658-664, ELM",,,,,,,,,,,
724,663,D,N,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM|FHA phosphopeptide ligands, 658-664, ELM",,"cBioPortal,COSMIC",coad_cptac_2019,Colon Adenocarcinoma,"hg19,12:132401051-132401051, hg38,12:131916506-131916506","hg19,12:g.132401051G>A, hg38,12:g.131916506G>A",0.188,large_intestine,"carcinoma, adenocarcinoma",0.0001166973835642,0.0001274778507234
725,664,L,P,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM|FHA phosphopeptide ligands, 658-664, ELM",,COSMIC,,,"hg38,12:131916510-131916510","hg38,12:g.131916510T>C",0.132,"skin, extremity","malignant_melanoma, in_situ_melanotic_neoplasm",,
726,665,S,L,P,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM",,"cBioPortal,Manual annotations from clinvar.csv","dlbc_tcga, gbm_mayo_pdx_sarkaria_2019","Diffuse Large B-Cell Lymphoma, NOS, Glioblastoma Multiforme","hg19,12:132401058-132401058","hg19,12:g.132401058C>T",0.079,,,0.0017116805077851,0.0012105766167569
727,666,E,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM",,,,,,,,,,,
728,667,V,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 661-667, ELM",,,,,,,,,,,
729,668,G,,,,,,,,,,,s,,,,,,,,,,,,
730,669,P,,,,,,,,,,,s,,,,,,,,,,,,
731,670,F,,,,,,,,,,,s,,,,,,,,,,,,
732,671,H,,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,,,,,,,,,,
733,672,G,,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,,,,,,,,,,
734,673,Q,,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,,,,,,,,,,
735,674,P,S,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,COSMIC,,,"hg38,12:131916539-131916539","hg38,12:g.131916539C>T",0.095,large_intestine,"carcinoma, adenocarcinoma",,
736,675,L,,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,,,,,,,,,,
737,676,G,V,,,,,,,,,,s,"SH3 ligand, 671-677, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,12:132401091-132401091","hg19,12:g.132401091G>T",0.197,,,,
738,677,P,L,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM|SH3 ligand, 671-677, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132401094-132401094","hg19,12:g.132401094C>T",0.076,,,0.0000041526169792,
739,678,G,,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM",,,,,,,,,,,
740,679,L,,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM",,,,,,,,,,,
741,680,R,Q,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM",,"cBioPortal,COSMIC",escc_icgc,Esophageal Squamous Cell Carcinoma,"hg19,12:132401103-132401103, hg38,12:131916558-131916558","hg19,12:g.132401103G>A, hg38,12:g.131916558G>A",0.141,oesophagus,carcinoma,0.0000343170899108,
742,680,R,W,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM",,"cBioPortal,COSMIC","blca_tcga_pan_can_atlas_2018, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, paad_cptac_2021, tgct_tcga","Bladder Urothelial Carcinoma, Head and Neck Squamous Cell Carcinoma, Non-Seminomatous Germ Cell Tumor, Pancreatic Adenocarcinoma","hg19,12:132401102-132401102, hg38,12:131916557-131916557","hg19,12:g.132401102C>T, hg38,12:g.131916557C>T",0.259,"upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma",0.0008351821553696,0.0007965334862678
743,681,P,,,,,,,,,,,s,"MYND domain binding motif., 677-681, ELM",,,,,,,,,,,
744,682,G,,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,,,,,,,,,,
745,683,E,D,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,12:132401113-132401114",,,,,,
746,683,E,G,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,cBioPortal,cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,12:132401112-132401112","hg19,12:g.132401112A>G",0.199,,,,
747,684,D,N,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,COSMIC,,,"hg38,12:131916569-131916569","hg38,12:g.131916569G>A",0.073,stomach,"carcinoma, intestinal_adenocarcinoma",,
748,685,P,R,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,cBioPortal,luad_cptac_2020,Lung Adenocarcinoma,"hg19,12:132401118-132401118","hg19,12:g.132401118C>G",0.045,,,,
749,686,K,M,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132401121-132401121","hg19,12:g.132401121A>T",0.204,,,,
750,687,G,,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,,,,,,,,,,
751,688,P,L,,,,,,,,,,s,"SH3 ligand, 682-688, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,12:132401127-132401127, hg38,12:131916582-131916582","hg19,12:g.132401127C>T, hg38,12:g.131916582C>T",0.181,skin,malignant_melanoma,0.0000047285795347,
752,689,F,,,,,,,,,,,s,"Pex14 ligand motif, 689-693, ELM",,,,,,,,,,,
753,690,G,,,,,,,,,,,s,"Pex14 ligand motif, 689-693, ELM",,,,,,,,,,,
754,691,R,Q,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|Pex14 ligand motif, 689-693, ELM",,cBioPortal,"ccle_broad_2019, skcm_broad","Cutaneous Melanoma, Mixed Cancer Types","hg19,12:132401136-132401136","hg19,12:g.132401136G>A",0.220,,,0.0000146069275789,0.0000637186185803
755,691,R,W,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|Pex14 ligand motif, 689-693, ELM",,cBioPortal,mel_ucla_2016,Melanoma,"hg19,12:132401135-132401135","hg19,12:g.132401135C>T",0.353,,,0.0000959094614684,0.0001274453578028
756,692,S,F,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|Pex14 ligand motif, 689-693, ELM",,cBioPortal,"hnsc_tcga, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,12:132401500-132401500","hg19,12:g.132401500C>T",0.412,,,,
757,693,F,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|FHA phosphopeptide ligands, 693-699, ELM|Pex14 ligand motif, 689-693, ELM",,,,,,,,,,,
758,694,S,,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|FHA phosphopeptide ligands, 693-699, ELM",,,,,,,,,,,
759,695,T,A,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|FHA phosphopeptide ligands, 693-699, ELM",,COSMIC,,,"hg38,12:131916963-131916963","hg38,12:g.131916963A>G",0.117,"skin, trunk","malignant_melanoma, superficial_spreading",,
760,696,S,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|FHA phosphopeptide ligands, 693-699, ELM",,,,,,,,,,,
761,697,R,H,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 693-699, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132401515-132401515","hg19,12:g.132401515G>A",0.167,,,0.0000120931657489,
762,697,R,L,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 693-699, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132401515-132401515, hg38,12:131916970-131916970","hg19,12:g.132401515G>T, hg38,12:g.131916970G>T",0.214,lung,"carcinoma, squamous_cell_carcinoma",,
763,698,L,F,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 693-699, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132401517-132401517","hg19,12:g.132401517C>T",0.125,,,0.0000926522719948,
764,699,T,,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 693-699, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,,,,,,,,,,
765,700,D,G,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132401524-132401524","hg19,12:g.132401524A>G",0.339,,,,
766,700,D,N,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,COSMIC,,,"hg38,12:131916978-131916978","hg38,12:g.131916978G>A",0.245,stomach,carcinoma,,
767,700,D,Y,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,COSMIC,,,"hg38,12:131916978-131916978","hg38,12:g.131916978G>T",0.459,liver,"other, neoplasm",,
768,701,L,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 691-701, ELM|14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,,,,,,,,,,
769,702,L,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,,,,,,,,,,
770,703,L,F,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 697-703, ELM|FHA phosphopeptide ligands, 697-703, ELM|Nuclear receptor box, 697-703, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132401531-132401532","hg19,12:g.132401531_132401532delinsTT",,,,,
771,704,K,,,,,,,,,,,s,"PCSK cleavage site, 704-708, ELM",,,,,,,,,,,
772,705,A,V,,,,,,,,,,s,"PCSK cleavage site, 704-708, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132401539-132401539","hg19,12:g.132401539C>T",0.261,,,0.0018342336531484,0.0025971527510581
773,706,A,V,,,,,,,,,,s,"PCSK cleavage site, 704-708, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132401542-132401542, hg38,12:131916997-131916997","hg19,12:g.132401542C>T, hg38,12:g.131916997C>T",0.175,stomach,"carcinoma, adenocarcinoma",0.0001250766598883,0.0000641683778234
774,707,F,L,,,,,,,,,,s,"PCSK cleavage site, 704-708, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132401546-132401546, hg38,12:131917001-131917001","hg19,12:g.132401546T>A, hg38,12:g.131917001T>A",0.219,lung,"carcinoma, adenocarcinoma",,
775,708,G,,,,,,,,,,,s,"PCSK cleavage site, 704-708, ELM",,,,,,,,,,,
776,709,T,,P,,,,,,,,,s,,,,,,,,,,,,
777,710,Q,,,,,,,,,,,s,,,,,,,,,,,,
778,711,A,,,,,,,,,,,s,,,,,,,,,,,,
779,712,P,L,,,,,,,,,,s,,,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,12:132401560-132401560","hg19,12:g.132401560C>T",0.064,,,0.0007827056091066,0.0011928429423459
780,712,P,S,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132401559-132401559","hg19,12:g.132401559C>T",0.038,,,0.0000127106795129,
781,713,D,Y,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132401562-132401562, hg38,12:131917017-131917017","hg19,12:g.132401562G>T, hg38,12:g.131917017G>T",0.185,"lung, lung, right_upper_lobe","carcinoma, adenocarcinoma",,
782,714,P,L,,,,,,,,,,s,,,"cBioPortal,COSMIC","brca_tcga_pub, sclc_cancercell_gardner_2017","Invasive Breast Carcinoma, Small Cell Lung Cancer","hg19,12:132401566-132401566, hg38,12:131917021-131917021","hg19,12:g.132401566C>T, hg38,12:g.131917021C>T",0.036,"haematopoietic_and_lymphoid_tissue, large_intestine, colon, sigmoid, thyroid","carcinoma, adenocarcinoma, lymphoid_neoplasm, plasma_cell_myeloma, other, neoplasm",0.2587056651791315,0.2340056837873432
783,715,G,,,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM",,,,,,,,,,,
784,716,S,,P,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM",,,,,,,,,,,
785,717,T,M,P,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, nepc_wcm_2016","Colorectal Adenocarcinoma, Prostate Adenocarcinoma","hg19,12:132401575-132401575, hg38,12:131917030-131917030","hg19,12:g.132401575C>T, hg38,12:g.131917030C>T",0.079,large_intestine,"carcinoma, adenocarcinoma",0.0002996663416554,0.0005069524913094
786,718,E,D,,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, escc_icgc","Esophageal Squamous Cell Carcinoma, Mixed Cancer Types","hg19,12:132401579-132401579, hg38,12:131917034-131917034","hg19,12:g.132401579G>T, hg38,12:g.131917034G>T",0.100,"large_intestine, rectum, oesophagus","carcinoma, carcinoma, adenocarcinoma",,
787,718,E,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,12:132401578-132401578","hg19,12:g.132401578A>T",0.138,,,,
788,719,S,,P,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM|TRAF2 binding site, 719-722, ELM",,,,,,,,,,,
789,720,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM|TRAF2 binding site, 719-722, ELM",,,,,,,,,,,
790,721,Q,,,,,,,,,,,s,"FHA phosphopeptide ligands, 715-721, ELM|TRAF2 binding site, 719-722, ELM",,,,,,,,,,,
791,722,E,,,,,,,,,,,s,"TRAF2 binding site, 719-722, ELM",,,,,,,,,,,
792,723,K,,,,,,,,,,,s,,,,,,,,,,,,
793,724,P,,,,,,,,,,,s,,,,,,,,,,,,
794,725,M,,,,,,,,,,,s,,,,,,,,,,,,
795,726,E,,,,,,,,,,,s,,,,,,,,,,,,
796,727,I,,,,,,,,,,,d,,,,,,,,,,,,
797,728,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,12:132401607-132401607, hg38,12:131917062-131917062","hg19,12:g.132401607G>A, hg38,12:g.131917062G>A",0.097,placenta,choriocarcinoma,,
798,729,P,,,,,,,,,,,d,"BRCT phosphopeptide ligands, 729-733, ELM",,,,,,,,,,,
799,730,S,,,,,,,,,,,d,"BRCT phosphopeptide ligands, 729-733, ELM",,,,,,,,,,,
800,731,A,,,,,,,,,,,d,"BRCT phosphopeptide ligands, 729-733, ELM",,,,,,,,,,,
801,732,G,V,,,,,,,,,,d,"BRCT phosphopeptide ligands, 729-733, ELM",,COSMIC,,,"hg38,12:131917423-131917423","hg38,12:g.131917423G>T",0.170,liver,"other, neoplasm",,
802,733,F,,,,,,,,,,,d,"BRCT phosphopeptide ligands, 729-733, ELM",,,,,,,,,,,
803,734,G,,,,,,,,,,,d,,,,,,,,,,,,
804,735,G,,,,,,,,,,,d,,,,,,,,,,,,
805,736,S,I,,,,,,,,,,d,,,COSMIC,,,"hg38,12:131917435-131917435","hg38,12:g.131917435G>T",0.024,"biliary_tract, bile_duct",carcinoma,,
806,737,L,,,,,,,,,,,d,,,,,,,,,,,,
807,738,H,,,,,,,,,,,d,,,,,,,,,,,,
808,739,P,,,,,,,,,,,d,,,,,,,,,,,,
809,740,G,R,,,,,,,,,,d,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132401991-132401991","hg19,12:g.132401991G>A",0.203,,,0.0000000000000000,
810,741,A,,,,,,,,,,,d,,,,,,,,,,,,
811,742,R,C,,,,,,,,,,d,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132401997-132401997, hg38,12:131917452-131917452","hg19,12:g.132401997C>T, hg38,12:g.131917452C>T",0.167,skin,malignant_melanoma,0.0005262775842044,
812,742,R,H,,,,,,,,,,d,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132401998-132401998, hg38,12:131917453-131917453","hg19,12:g.132401998G>A, hg38,12:g.131917453G>A",0.112,endometrium,"carcinoma, endometrioid_carcinoma",0.0001444982298967,0.0000640532923392
813,742,R,L,,,,,,,,,,d,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132401998-132401998, hg38,12:131917453-131917453","hg19,12:g.132401998G>T, hg38,12:g.131917453G>T",0.190,kidney,,0.0000060207595790,
814,743,A,,,,,,,,,,,d,,,,,,,,,,,,
815,744,G,E,,,,,,,,,,d,,,"cBioPortal,COSMIC",mbl_broad_2012,Medulloblastoma,"hg19,12:132402004-132402004, hg38,12:131917459-131917459","hg19,12:g.132402004G>A, hg38,12:g.131917459G>A",0.125,"central_nervous_system, brain",primitive_neuroectodermal_tumour-medulloblastoma,,
816,745,G,,,,,,,,,,,d,"WW domain ligands, 745-750, ELM",,,,,,,,,,,
817,746,T,,,,,,,,,,,d,"WW domain ligands, 745-750, ELM",,,,,,,,,,,
818,747,S,C,,,,,,,,,,d,"WW domain ligands, 745-750, ELM|WW domain ligands, 747-752, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132402012-132402012","hg19,12:g.132402012A>T",0.148,,,,
819,748,S,,P,,,,,,,,,d,"WW domain ligands, 745-750, ELM|WW domain ligands, 747-752, ELM",,,,,,,,,,,
820,749,P,L,,,,,,,,,,d,"WW domain ligands, 745-750, ELM|WW domain ligands, 747-752, ELM",,cBioPortal,nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,12:132402019-132402019","hg19,12:g.132402019C>T",0.305,,,,
821,749,P,S,,,,,,,,,,d,"WW domain ligands, 745-750, ELM|WW domain ligands, 747-752, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,12:132402018-132402018","hg19,12:g.132402018C>T",0.232,,,,
822,750,S,F,,,,,,,,,,d,"WW domain ligands, 745-750, ELM|WW domain ligands, 747-752, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,12:132402022-132402023","hg19,12:g.132402022_132402023delinsTT",,,,,
823,751,P,L,,,,,,,,,,d,"WW domain ligands, 747-752, ELM",,"cBioPortal,COSMIC",paad_qcmg_uq_2016,Pancreatic Adenocarcinoma,"hg19,12:132402025-132402025, hg38,12:131917480-131917480","hg19,12:g.132402025C>T, hg38,12:g.131917480C>T",0.227,pancreas,"carcinoma, ductal_carcinoma",0.0000200534759358,
824,752,V,,,,,,,,,,,d,"WW domain ligands, 747-752, ELM",,,,,,,,,,,
825,753,V,,,,,,,,,,,d,"SH3 ligand, 753-759, ELM",,,,,,,,,,,
826,754,F,,,,,,,,,,,d,"SH3 ligand, 753-759, ELM",,,,,,,,,,,
827,755,T,I,,,,,,,,,O-GlcNAc,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,"cBioPortal,COSMIC","sarc_tcga, sarc_tcga_pan_can_atlas_2018",Soft Tissue,"hg19,12:132402037-132402037, hg38,12:131917492-131917492","hg19,12:g.132402037C>T, hg38,12:g.131917492C>T",0.372,soft_tissue,sarcoma,,
828,756,V,M,,,,,,,,,,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132402039-132402039","hg19,12:g.132402039G>A",0.173,,,0.0001238202680021,0.0000959815715383
829,757,G,,,,,,,,,,,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,,,,,,,,,,
830,758,S,,P,,,,,,,,,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,,,,,,,,,,
831,759,P,F,,,,,,,,,,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132402048-132402049, hg38,12:131917503-131917504","hg19,12:g.132402048_132402049delinsTT, hg38,12:g.131917503_131917504delinsTT",,"skin, lower_leg",malignant_melanoma,,
832,759,P,S,,,,,,,,,,d,"WW domain ligands, 755-760, ELM|SH3 ligand, 753-759, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132402048-132402048, hg38,12:131917503-131917503","hg19,12:g.132402048C>T, hg38,12:g.131917503C>T",0.270,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
833,760,P,L,,,,,,,,,,d,"USP7 binding motif, 760-764, ELM|WW domain ligands, 755-760, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,12:132402051-132402052, hg38,12:131917506-131917507","hg19,12:g.132402051_132402052delinsTT, hg38,12:g.131917506_131917507delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,
834,761,S,,P,,,,,,,,,d,"USP7 binding motif, 760-764, ELM|WW domain ligands, 761-766, ELM",,,,,,,,,,,
835,762,G,R,,,,,,,,,,d,"USP7 binding motif, 760-764, ELM|WW domain ligands, 761-766, ELM",,"cBioPortal,COSMIC",cellline_ccle_broad,Mixed Cancer Types,"hg19,12:132402057-132402057, hg38,12:131917512-131917512","hg19,12:g.132402057G>A, hg38,12:g.131917512G>A",0.265,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0004851709836450,0.0004156807571785
836,763,S,,,,,,,,,,,d,"USP7 binding motif, 760-764, ELM|WW domain ligands, 761-766, ELM|SH3 ligand, 763-769, ELM",,,,,,,,,,,
837,764,T,M,P,,,,,,,,,d,"USP7 binding motif, 760-764, ELM|WW domain ligands, 761-766, ELM|SH3 ligand, 763-769, ELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,12:132402064-132402064","hg19,12:g.132402064C>T",0.271,,,0.0000630348109744,0.0000640081930487
838,765,P,,,,,,,,,,,d,"WW domain ligands, 761-766, ELM|SH3 ligand, 763-769, ELM",,,,,,,,,,,
839,766,P,A,,,,,,,,,,d,"WW domain ligands, 761-766, ELM|SH3 ligand, 763-769, ELM",,"cBioPortal,COSMIC",chol_jhu_2013,Cholangiocarcinoma,"hg19,12:132402069-132402069, hg38,12:131917524-131917524","hg19,12:g.132402069C>G, hg38,12:g.131917524C>G",0.323,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,
840,767,Q,L,,,,,,,,,,d,"SH3 ligand, 763-769, ELM",,COSMIC,,,"hg38,12:131917528-131917528","hg38,12:g.131917528A>T",0.200,lung,"carcinoma, adenocarcinoma",,
841,768,G,C,,,,,,,,,,d,"SH3 ligand, 763-769, ELM",,"cBioPortal,COSMIC",sclc_ucologne_2015,Small Cell Lung Cancer,"hg19,12:132402075-132402075, hg38,12:131917530-131917530","hg19,12:g.132402075G>T, hg38,12:g.131917530G>T",0.079,lung,"carcinoma, small_cell_carcinoma",,
842,769,P,L,,,,,,,,,,d,"SH3 ligand, 763-769, ELM|di Arginine retention/retrieving signal, 769-772, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132402079-132402079, hg38,12:131917534-131917534","hg19,12:g.132402079C>T, hg38,12:g.131917534C>T",0.028,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
843,770,R,C,,,,,,,,,,d,"di Arginine retention/retrieving signal, 769-772, ELM|di Arginine retention/retrieving signal, 770-773, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, stad_tcga","Bladder Urothelial Carcinoma, Stomach Adenocarcinoma","hg19,12:132402081-132402081, hg38,12:131917536-131917536","hg19,12:g.132402081C>T, hg38,12:g.131917536C>T",0.139,"stomach, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma",0.0000083958826591,
844,771,T,S,,,,,,,,,,d,"di Arginine retention/retrieving signal, 769-772, ELM|di Arginine retention/retrieving signal, 770-773, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132402085-132402085, hg38,12:131917540-131917540","hg19,12:g.132402085C>G, hg38,12:g.131917540C>G",0.129,ovary,"carcinoma, mixed_adenosquamous_carcinoma",,
845,772,R,,,,,,,,,,,d,"di Arginine retention/retrieving signal, 769-772, ELM|di Arginine retention/retrieving signal, 770-773, ELM",,,,,,,,,,,
846,773,M,,,,,,,,,,,d,"di Arginine retention/retrieving signal, 770-773, ELM",,,,,,,,,,,
847,774,F,,,,,,,,,,,d,,,,,,,,,,,,
848,775,S,L,P,,,,,,,,,d,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132402097-132402097, hg38,12:131917552-131917552","hg19,12:g.132402097C>T, hg38,12:g.131917552C>T",0.200,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
849,775,S,P,P,,,,,,,,,d,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132402096-132402096","hg19,12:g.132402096T>C",0.226,,,0.0000084560875374,0.0000319938571794
850,776,A,,,,,,,,,,,d,,,,,,,,,,,,
851,777,G,,,,,,,,,,,d,,,,,,,,,,,,
852,778,P,,,,,,,,,,,d,"USP7 binding motif, 778-782, ELM",,,,,,,,,,,
853,779,T,I,,,,,,,,,,d,"USP7 binding motif, 778-782, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,12:132403051-132403051, hg38,12:131918506-131918506","hg19,12:g.132403051C>T, hg38,12:g.131918506C>T",0.126,lung,"carcinoma, large_cell_carcinoma, carcinoma, large_cell_neuroendocrine_carcinoma",,
854,780,G,,,,,,,,,,,d,"USP7 binding motif, 778-782, ELM",,,,,,,,,,,
855,781,S,,P,,,,,,,,,d,"USP7 binding motif, 778-782, ELM",,,,,,,,,,,
856,782,A,,,,,,,,,,,d,"USP7 binding motif, 778-782, ELM|USP7 binding motif, 782-786, ELM",,,,,,,,,,,
857,783,S,,,,,,,,,,,d,"USP7 binding motif, 782-786, ELM",,,,,,,,,,,
858,784,S,C,,,,,,,,,,d,"USP7 binding motif, 782-786, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,12:132403066-132403066, hg38,12:131918521-131918521","hg19,12:g.132403066C>G, hg38,12:g.131918521C>G",0.236,lung,"carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma",,
859,785,S,F,,,,,,,,,,d,"USP7 binding motif, 782-786, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,12:132403069-132403069, hg38,12:131918524-131918524","hg19,12:g.132403069C>T, hg38,12:g.131918524C>T",0.116,breast,"carcinoma, ER-PR-positive_carcinoma",,
860,786,A,,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|USP7 binding motif, 782-786, ELM",,,,,,,,,,,
861,787,R,C,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,"cBioPortal,COSMIC","sarc_tcga, sarc_tcga_pan_can_atlas_2018, sarc_tcga_pub",Soft Tissue,"hg19,12:132403074-132403074, hg38,12:131918529-131918529","hg19,12:g.132403074C>T, hg38,12:g.131918529C>T",0.192,soft_tissue,sarcoma,0.0000166161259502,
862,787,R,H,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132403075-132403075","hg19,12:g.132403075G>A",0.170,,,0.0000291443226859,
863,788,H,,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,,,,,,,,,,
864,789,L,,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,,,,,,,,,,
865,790,V,,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,,,,,,,,,,
866,791,P,L,,,,,,,,,,d,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,12:132403087-132403087, hg38,12:131918542-131918542","hg19,12:g.132403087C>T, hg38,12:g.131918542C>T",0.127,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
867,792,G,E,,,,,,,,,,s,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132403090-132403090","hg19,12:g.132403090G>A",0.262,,,,
868,793,P,,,,,,,,,,,s,"Tankyrase-binding motif, 786-793, ELM|SH3 ligand, 787-793, ELM",,,,,,,,,,,
869,794,C,F,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131918551-131918551","hg38,12:g.131918551G>T",0.038,thyroid,carcinoma,,
870,795,S,,,,,,,,,,,s,,,,,,,,,,,,
871,796,E,,,,,,,,,,,s,,,,,,,,,,,,
872,797,A,,,,,,,,,,,s,"SH3 ligand, 797-803, ELM",,,,,,,,,,,
873,798,P,,,,,,,,,,,s,"SH3 ligand, 797-803, ELM",,,,,,,,,,,
874,799,A,T,,,,,,,,,,s,"SH3 ligand, 797-803, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132403110-132403110, hg38,12:131918565-131918565","hg19,12:g.132403110G>A, hg38,12:g.131918565G>A",0.031,endometrium,"carcinoma, endometrioid_carcinoma",,
875,800,P,,,,,,,,,,,s,"SH3 ligand, 797-803, ELM",,,,,,,,,,,
876,801,E,,,,,,,,,,,s,"SH3 ligand, 797-803, ELM",,,,,,,,,,,
877,802,L,,,,,,,,,,,s,"Calcineurin (PP2B)-docking motif LxvP, 802-805, ELM|SH3 ligand, 797-803, ELM",,,,,,,,,,,
878,803,P,S,,,,,,,,,,s,"Calcineurin (PP2B)-docking motif LxvP, 802-805, ELM|SH3 ligand, 797-803, ELM",,COSMIC,,,"hg38,12:131918576-131918577","hg38,12:g.131918576_131918577delinsTT",,"skin, trunk",malignant_melanoma,,
879,804,A,,,,,,,,,,,s,"Calcineurin (PP2B)-docking motif LxvP, 802-805, ELM",,,,,,,,,,,
880,805,P,S,,,,,,,,,,s,"Calcineurin (PP2B)-docking motif LxvP, 802-805, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,12:132403128-132403128, hg38,12:131918583-131918583","hg19,12:g.132403128C>T, hg38,12:g.131918583C>T",0.075,lung,"carcinoma, mixed_adenosquamous_carcinoma",,
881,806,G,,,,,,,,,,,s,,,,,,,,,,,,
882,807,H,Y,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132403134-132403134, hg38,12:131918589-131918589","hg19,12:g.132403134C>T, hg38,12:g.131918589C>T",0.073,stomach,"carcinoma, adenocarcinoma",,
883,808,G,S,,,,,,,,,,s,,,cBioPortal,mel_ucla_2016,Melanoma,"hg19,12:132403137-132403137","hg19,12:g.132403137G>A",0.015,,,0.0007065628183641,0.0004157073420312
884,809,C,,,,,,,,,,,s,,,,,,,,,,,,
885,810,S,,,,,,,,,,,s,,,,,,,,,,,,
886,811,F,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 811-814, ELM",,,,,,,,,,,
887,812,A,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 811-814, ELM",,,,,,,,,,,
888,813,D,Y,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 811-814, ELM",,COSMIC,,,"hg38,12:131918607-131918607","hg38,12:g.131918607G>T",0.447,liver,"other, neoplasm",0.0000164838334803,
889,814,P,L,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 811-814, ELM|FHA phosphopeptide ligands, 814-820, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_tcga, prad_tcga_pan_can_atlas_2018",Prostate Adenocarcinoma,"hg19,12:132403156-132403156, hg38,12:131918611-131918611","hg19,12:g.132403156C>T, hg38,12:g.131918611C>T",0.199,prostate,"carcinoma, adenocarcinoma",0.0000000000000000,
890,815,I,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,cBioPortal,"aml_ohsu_2018, coad_cptac_2019, mds_mskcc_2020","Acute Myeloid Leukemia, Colon Adenocarcinoma, Myelodysplastic Syndromes","hg19,12:132403158-132403158","hg19,12:g.132403158A>G",0.112,,,,
891,816,T,A,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,"cBioPortal,COSMIC",mixed_pipseq_2017,Mixed Cancer Types,"hg19,12:132403161-132403161, hg38,12:131918616-131918616","hg19,12:g.132403161A>G, hg38,12:g.131918616A>G",0.038,thyroid,"other, neoplasm",0.9981205017478922,0.9939570277529096
892,817,A,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132403165-132403165","hg19,12:g.132403165C>T",0.086,,,0.0000041360940382,
893,818,N,,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,,,,,,,,,,
894,819,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,,,,,,,,,,
895,820,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 814-820, ELM",,,,,,,,,,,
896,821,G,,,,,,,,,,,s,,,,,,,,,,,,
897,822,A,,,,,,,,,,,s,,,,,,,,,,,,
898,823,V,,,,,,,,,,,s,,,,,,,,,,,,
899,824,T,,,,,,,,,,,s,,,,,,,,,,,,
900,825,F,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 825-828, ELM|SH3 ligand, 825-831, ELM",,,,,,,,,,,
901,826,E,K,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 825-828, ELM|SH3 ligand, 825-831, ELM",,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,12:132403191-132403191, hg38,12:131918646-131918646","hg19,12:g.132403191G>A, hg38,12:g.131918646G>A",0.212,liver,"carcinoma, hepatocellular_carcinoma",0.0000126839167935,0.0000320102432778
902,827,A,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 825-828, ELM|SH3 ligand, 825-831, ELM",,,,,,,,,,,
903,828,P,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 825-828, ELM|SH3 ligand, 825-831, ELM",,,,,,,,,,,
904,829,D,,,,,,,,,,,s,"SH3 ligand, 825-831, ELM",,,,,,,,,,,
905,830,L,,,,,,,,,,,s,"SH3 ligand, 825-831, ELM",,,,,,,,,,,
906,831,P,S,,,,,,,,,,s,"SH3 ligand, 825-831, ELM",,"cBioPortal,COSMIC",desm_broad_2015,Desmoplastic Melanoma,"hg19,12:132403206-132403206, hg38,12:131918661-131918661","hg19,12:g.132403206C>T, hg38,12:g.131918661C>T",0.364,"skin, scalp","malignant_melanoma, desmoplastic",,
907,832,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
908,833,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
909,834,T,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
910,835,L,F,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,COSMIC,,,"hg38,12:131918673-131918673","hg38,12:g.131918673C>T",0.311,thyroid,carcinoma,,
911,836,M,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
912,837,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
913,838,Q,,,,,,,,,,,s,"FHA phosphopeptide ligands, 832-838, ELM",,,,,,,,,,,
914,839,E,D,,,,,,,,,,s,"FHA phosphopeptide ligands, 839-845, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132403762-132403762, hg38,12:131919217-131919217","hg19,12:g.132403762G>C, hg38,12:g.131919217G>C",0.161,stomach,"carcinoma, adenocarcinoma",,
915,839,E,Q,,,,,,,,,,s,"FHA phosphopeptide ligands, 839-845, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132403760-132403760, hg38,12:131919215-131919215","hg19,12:g.132403760G>C, hg38,12:g.131919215G>C",0.259,lung,"carcinoma, adenocarcinoma",,
916,840,H,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,,,,,,,,,,
917,841,T,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,,,,,,,,,,
918,842,E,,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,,,,,,,,,,
919,843,I,,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|PP1-docking motif RVXF, 843-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,,,,,,,,,,
920,844,L,,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|PP1-docking motif RVXF, 843-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,,,,,,,,,,
921,845,R,C,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132403778-132403778","hg19,12:g.132403778C>T",0.044,,,0.0000507137966884,0.0000641477965232
922,845,R,H,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM|FHA phosphopeptide ligands, 839-845, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,12:132403779-132403779","hg19,12:g.132403779G>A",0.033,,,0.0000168874703414,
923,846,G,D,,,,,,,,,,s,"Separase cleavage motif, 842-846, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,12:132403782-132403782","hg19,12:g.132403782G>A",0.034,,,,
924,847,L,,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM",,,,,,,,,,,
925,848,R,,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM|14-3-3 binding phosphopeptide motif, 848-852, ELM",,,,,,,,,,,
926,849,F,S,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM|14-3-3 binding phosphopeptide motif, 848-852, ELM|Pex14 ligand motif, 849-853, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,12:132403791-132403791","hg19,12:g.132403791T>C",0.441,,,,
927,850,T,M,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|Cyclin N-terminal Domain Docking Motifs, 840-850, ELM|Cyclin N-terminal Domain Docking Motifs, 842-850, ELM|MAPK docking motifs, 845-854, ELM|PP1-docking motif RVXF, 843-850, ELM|14-3-3 binding phosphopeptide motif, 848-852, ELM|Actin-binding motifs, 850-866, ELM|Pex14 ligand motif, 849-853, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, stad_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Stomach Adenocarcinoma","hg19,12:132403794-132403794, hg38,12:131919249-131919249","hg19,12:g.132403794C>T, hg38,12:g.131919249C>T",0.207,"large_intestine, large_intestine, colon, transverse, stomach","carcinoma, carcinoma, adenocarcinoma",0.0004124544406192,0.0018257527226137
928,851,L,,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|MAPK docking motifs, 845-854, ELM|14-3-3 binding phosphopeptide motif, 848-852, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM|Pex14 ligand motif, 849-853, ELM",,,,,,,,,,,
929,852,L,,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|MAPK docking motifs, 845-854, ELM|14-3-3 binding phosphopeptide motif, 848-852, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM|Pex14 ligand motif, 849-853, ELM",,,,,,,,,,,
930,853,F,L,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|MAPK docking motifs, 845-854, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM|Pex14 ligand motif, 849-853, ELM",,COSMIC,,,"hg38,12:131919259-131919259","hg38,12:g.131919259C>A",0.316,liver,carcinoma,0.0000042016453643,0.0000320307495195
931,853,F,V,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|MAPK docking motifs, 845-854, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM|Pex14 ligand motif, 849-853, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132403802-132403802, hg38,12:131919257-131919257","hg19,12:g.132403802T>G, hg38,12:g.131919257T>G",0.492,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
932,854,V,L,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|MAPK docking motifs, 845-854, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,COSMIC,,,"hg38,12:131919260-131919260","hg38,12:g.131919260G>T",0.102,liver,"other, neoplasm",,
933,855,Q,,,,,,,,,,,s,"APCC-binding Destruction motifs, 847-855, ELM|Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
934,856,H,Q,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,12:132403813-132403813","hg19,12:g.132403813C>A",0.014,,,0.0000000000000000,
935,857,V,I,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,12:132403814-132403814, hg38,12:131919269-131919269","hg19,12:g.132403814G>A, hg38,12:g.131919269G>A",0.052,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000251865906591,0.0000320286977132
936,858,L,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
937,859,E,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
938,860,I,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
939,861,A,T,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,COSMIC,,,"hg38,12:131919281-131919281","hg38,12:g.131919281G>A",0.243,thyroid,carcinoma,0.0000042151407857,0.0000320615581917
940,862,A,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
941,863,L,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
942,864,K,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
943,865,G,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
944,866,S,,,,,,,,,,,s,"Actin-binding motifs, 850-866, ELM|Actin-binding motifs, 851-866, ELM",,,,,,,,,,,
945,867,A,T,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919299-131919299","hg38,12:g.131919299G>A",0.036,thymus,"thymic_carcinoma, squamous_cell_carcinoma",0.0000514818183378,0.0000320656704932
946,868,S,,,,,,,,,,,s,,,,,,,,,,,,
947,869,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, luad_oncosg_2020","Bladder Urothelial Carcinoma, Lung Adenocarcinoma","hg19,12:132403850-132403850, hg38,12:131919305-131919305","hg19,12:g.132403850G>A, hg38,12:g.131919305G>A",0.048,"urinary_tract, bladder",carcinoma,,
948,870,A,V,,,,,,,,,,s,,,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,12:132403854-132403854","hg19,12:g.132403854C>T",0.018,,,0.0000659810502424,0.0000963638699730
949,871,A,V,,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, stad_oncosg_2018","Mixed Cancer Types, Stomach Adenocarcinoma","hg19,12:132403857-132403857","hg19,12:g.132403857C>T",0.042,,,0.0000088794175102,
950,872,G,E,,,,,,,,,,s,,,"cBioPortal,COSMIC",prad_fhcrc,Prostate Adenocarcinoma,"hg19,12:132403860-132403860, hg38,12:131919315-131919315","hg19,12:g.132403860G>A, hg38,12:g.131919315G>A",0.053,prostate,"carcinoma, adenocarcinoma",,
951,872,G,W,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919314-131919314","hg38,12:g.131919314G>T",0.104,parathyroid,carcinoma,,
952,873,G,,,,,,,,,,,s,,,,,,,,,,,,
953,874,P,,,,,,,,,,,s,,,,,,,,,,,,
954,875,E,,,,,,,,,,,s,,,,,,,,,,,,
955,876,Y,F,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 876-879, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,12:132403872-132403872","hg19,12:g.132403872A>T",0.115,,,,
956,877,Q,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 876-879, ELM",,,,,,,,,,,
957,878,L,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 876-879, ELM",,,,,,,,,,,
958,879,Q,P,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 876-879, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132403881-132403881, hg38,12:131919336-131919336","hg19,12:g.132403881A>C, hg38,12:g.131919336A>C",0.429,lung,"carcinoma, adenocarcinoma",,
959,880,E,,,,,,,,,,,s,,,,,,,,,,,,
960,881,S,,,,,,,,,,,s,,,,,,,,,,,,
961,882,V,G,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919345-131919345","hg38,12:g.131919345T>G",0.168,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
962,882,V,L,,,,,,,,,,s,,,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,12:132403889-132403889, hg38,12:131919344-131919344","hg19,12:g.132403889G>T, hg38,12:g.131919344G>T",0.007,soft_tissue,sarcoma,,
963,883,V,L,,,,,,,,,,s,,,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,12:132403892-132403892","hg19,12:g.132403892G>T",0.241,,,,
964,884,A,,,,,,,,,,,s,,,,,,,,,,,,
965,885,D,V,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,12:132403899-132403899","hg19,12:g.132403899A>T",0.727,,,,
966,886,Q,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
967,887,I,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
968,888,S,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
969,889,L,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
970,890,L,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
971,891,S,,,,,,,,,,,s,"SUMO interaction site, 885-891, ELM",,,,,,,,,,,
972,892,R,,,,,,,,,,,s,,,,,,,,,,,,
973,893,E,,,,,,,,,,,s,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 893-896, ELM",,,,,,,,,,,
974,894,W,G,,,,,,,,,,s,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 893-896, ELM",,COSMIC,,,"hg38,12:131919379-131919380","hg38,12:g.131919379_131919380delinsGG",,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
975,895,G,,,,,,,,,,,s,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 893-896, ELM",,,,,,,,,,,
976,896,F,,,,,,,,,,,s,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 893-896, ELM",,,,,,,,,,,
977,897,A,V,,,,,,,,,,s,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,12:132404022-132404022, hg38,12:131919477-131919477","hg19,12:g.132404022C>T, hg38,12:g.131919477C>T",0.236,"endometrium, large_intestine, colon, ascending","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000406593317232,
978,898,E,,,,,,,,,,,s,,,,,,,,,,,,
979,899,Q,,,,,,,,,,,s,,,,,,,,,,,,
980,900,L,,,,,,,,,,,s,,,,,,,,,,,,
981,901,V,,,,,,,,,,,s,"Immunoreceptor tyrosine-based motif, 901-906, ELM",,,,,,,,,,,
982,902,L,M,,,,,,,,,,s,"Immunoreceptor tyrosine-based motif, 901-906, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,12:132404036-132404036","hg19,12:g.132404036C>A",0.624,,,,
983,903,Y,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 903-906, ELM|Immunoreceptor tyrosine-based motif, 901-906, ELM|Y-based sorting signal, 903-906, ELM",,,,,,,,,,,
984,904,L,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 903-906, ELM|Immunoreceptor tyrosine-based motif, 901-906, ELM|Y-based sorting signal, 903-906, ELM",,,,,,,,,,,
985,905,K,M,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 903-906, ELM|Immunoreceptor tyrosine-based motif, 901-906, ELM|Y-based sorting signal, 903-906, ELM",,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,12:132404046-132404046","hg19,12:g.132404046A>T",0.653,,,,
986,906,V,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM|Phosphotyrosine ligands bound by SH2 domains, 903-906, ELM|Immunoreceptor tyrosine-based motif, 901-906, ELM|Y-based sorting signal, 903-906, ELM",,,,,,,,,,,
987,907,A,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
988,908,E,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
989,909,L,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
990,910,L,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
991,911,S,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
992,912,S,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
993,913,G,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
994,914,L,,,,,,,,,,,s,"GTPase-binding domain (GBD) ligand, 906-914, ELM",,,,,,,,,,,
995,915,Q,,,,,,,,,,,s,,,,,,,,,,,,
996,916,S,,,,,,,,,,,s,,,,,,,,,,,,
997,917,A,,,,,,,,,,,s,,,,,,,,,,,,
998,918,I,,,,,,,,,,,s,,,,,,,,,,,,
999,919,D,N,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132404087-132404087","hg19,12:g.132404087G>A",0.148,,,0.0000160408078151,
1000,919,D,V,,,,,,,,,,s,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132404088-132404088, hg38,12:131919543-131919543","hg19,12:g.132404088A>T, hg38,12:g.131919543A>T",0.126,lung,"carcinoma, squamous_cell_carcinoma",,
1001,920,Q,,,,,,,,,,,s,,,,,,,,,,,,
1002,921,I,V,,,,,,,,,,s,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,12:132404093-132404093","hg19,12:g.132404093A>G",0.110,,,,
1003,922,R,Q,,,,,,,,,,s,,,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,12:132404097-132404097, hg38,12:131919552-131919552","hg19,12:g.132404097G>A, hg38,12:g.131919552G>A",0.034,"small_intestine, duodenum","carcinoma, adenocarcinoma",0.0000080217549996,
1004,922,R,W,,,,,,,,,,s,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,12:132404096-132404096","hg19,12:g.132404096C>T",0.198,,,0.0000080205968928,
1005,923,A,,,,,,,,,,,s,,,,,,,,,,,,
1006,924,G,,,,,,,,,,,s,,,,,,,,,,,,
1007,925,K,,,,,,,,,,,s,,,,,,,,,,,,
1008,926,L,,,,,,,,,,,s,,,,,,,,,,,,
1009,927,C,F,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919567-131919567","hg38,12:g.131919567G>T",0.099,lung,"carcinoma, adenocarcinoma",,
1010,927,C,R,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,12:132404111-132404111, hg38,12:131919566-131919566","hg19,12:g.132404111T>C, hg38,12:g.131919566T>C",0.133,stomach,"carcinoma, adenocarcinoma",,
1011,928,L,,,,,,,,,,,s,,,,,,,,,,,,
1012,929,S,,,,,,,,,,,s,,,,,,,,,,,,
1013,930,S,F,,,,,,,,,,s,,,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,12:132404121-132404121, hg38,12:131919576-131919576","hg19,12:g.132404121C>T, hg38,12:g.131919576C>T",0.232,lung,"carcinoma, squamous_cell_carcinoma",,
1014,931,T,,,,,,,,,,,s,,,,,,,,,,,,
1015,932,V,L,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919581-131919581","hg38,12:g.131919581G>T",0.223,liver,"other, neoplasm",,
1016,932,V,M,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131919581-131919581","hg38,12:g.131919581G>A",0.246,stomach,carcinoma,,
1017,933,K,,,,,,,,,,,s,,,,,,,,,,,,
1018,934,Q,K,,,,,,,,,,s,,,cBioPortal,"tgct_tcga, tgct_tcga_pan_can_atlas_2018","Non-Seminomatous Germ Cell Tumor, Testis","hg19,12:132404132-132404132","hg19,12:g.132404132C>A",0.211,,,0.0000040253111566,
1019,935,V,A,,,,,,,,,,s,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,12:132404524-132404524","hg19,12:g.132404524T>C",0.259,,,,
1020,936,V,,,,,,,,,,,s,"di Arginine retention/retrieving signal, 936-938, ELM",,,,,,,,,,,
1021,937,R,H,,,,,,,,,,s,"NRD cleavage site, 937-939, ELM|di Arginine retention/retrieving signal, 936-938, ELM|di Arginine retention/retrieving signal, 937-939, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,12:132404530-132404530, hg38,12:131919985-131919985","hg19,12:g.132404530G>A, hg38,12:g.131919985G>A",0.183,"skin, head_neck",malignant_melanoma,,
1022,938,R,,,,,,,,,,,s,"NRD cleavage site, 937-939, ELM|di Arginine retention/retrieving signal, 936-938, ELM|di Arginine retention/retrieving signal, 937-939, ELM",,,,,,,,,,,
1023,939,L,,,,,,,,,,,s,"NRD cleavage site, 937-939, ELM|di Arginine retention/retrieving signal, 937-939, ELM",,,,,,,,,,,
1024,940,N,,,,,,,,,,,s,,,,,,,,,,,,
1025,941,E,G,,,,,,,,,,s,,,cBioPortal,lihc_tcga,Hepatocellular Carcinoma,"hg19,12:132404542-132404542","hg19,12:g.132404542A>G",0.178,,,,
1026,941,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,12:132404541-132404541, hg38,12:131919996-131919996","hg19,12:g.132404541G>A, hg38,12:g.131919996G>A",0.096,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
1027,942,L,,,,,,,,,,,s,,,,,,,,,,,,
1028,943,Y,,,,,,,,,,,s,,,,,,,,,,,,
1029,944,K,,,,,,,,,,,s,,,,,,,,,,,,
1030,945,A,,,,,,,,,,,s,,,,,,,,,,,,
1031,946,S,,,,,,,,,,,s,,,,,,,,,,,,
1032,947,V,,,,,,,,,,,s,,,,,,,,,,,,
1033,948,V,,,,,,,,,,,s,,,,,,,,,,,,
1034,949,S,,P,,,,,,,,,s,,,,,,,,,,,,
1035,950,C,F,,,,,,,,,,s,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132404569-132404569, hg38,12:131920024-131920024","hg19,12:g.132404569G>T, hg38,12:g.131920024G>T",0.662,large_intestine,"carcinoma, adenocarcinoma",,
1036,951,Q,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1037,952,G,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1038,953,L,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1039,954,S,N,P,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,COSMIC,,,"hg38,12:131920036-131920036","hg38,12:g.131920036G>A",0.104,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
1040,955,L,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1041,956,R,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1042,957,L,,,,,,,,,,,s,"NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1043,958,Q,,,,,,,,,,,s,"RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1044,959,R,C,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,cBioPortal,"mixed_allen_2018, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,12:132404595-132404595","hg19,12:g.132404595C>T",0.282,,,0.0000400461331454,0.0000955901096100
1045,959,R,H,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,"cBioPortal,COSMIC","aml_ohsu_2018, cellline_nci60, mds_mskcc_2020, pediatric_dkfz_2017","Acute Myeloid Leukemia, Mixed Cancer Types, Myelodysplastic Syndromes","hg19,12:132404596-132404596, hg38,12:131920051-131920051","hg19,12:g.132404596G>A, hg38,12:g.131920051G>A",0.125,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000720789985824,
1046,960,F,,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1047,961,F,,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1048,962,L,,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1049,963,D,,,,,,,,,,,s,"PCSK cleavage site, 959-963, ELM|RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM|NES Nuclear Export Signal, 951-963, ELM",,,,,,,,,,,
1050,964,K,,,,,,,,,,,s,"RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM",,,,,,,,,,,
1051,965,Q,,,,,,,,,,,s,"RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM",,,,,,,,,,,
1052,966,R,Q,,,,,,,,,,s,"RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132404617-132404617, hg38,12:131920072-131920072","hg19,12:g.132404617G>A, hg38,12:g.131920072G>A",0.080,large_intestine,"carcinoma, adenocarcinoma",0.0000240255631992,
1053,967,L,,,,,,,,,,,s,"RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM",,,,,,,,,,,
1054,968,L,,,,,,,,,,,s,"RIR motif, 958-968, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 963-968, ELM",,,,,,,,,,,
1055,969,D,,,,,,,,,,,s,,,,,,,,,,,,
1056,970,R,H,,,,,,,,,,s,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, prad_p1000, skcm_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Cutaneous Melanoma, Prostate Adenocarcinoma","hg19,12:132404629-132404629, hg38,12:131920084-131920084","hg19,12:g.132404629G>A, hg38,12:g.131920084G>A",0.151,"central_nervous_system, brain, large_intestine, colon, skin","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme, malignant_melanoma",0.0000200351014978,
1057,971,I,,,,,,,,,,,s,,,,,,,,,,,,
1058,972,H,,,,,,,,,,,s,,,,,,,,,,,,
1059,973,S,G,,,,,,,,,,s,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,12:132404637-132404637, hg38,12:131920092-131920092","hg19,12:g.132404637A>G, hg38,12:g.131920092A>G",0.058,large_intestine,"carcinoma, adenocarcinoma",0.0000080103814544,0.0000318613394507
1060,974,I,,,,,,,,,,,s,,,,,,,,,,,,
1061,975,T,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,,,,,,,,,,
1062,976,A,T,,,,,,,,,,s,"PP1-docking motif RVXF, 976-982, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,12:132404646-132404646","hg19,12:g.132404646G>A",0.650,,,,
1063,977,E,K,,,,,,,,,,s,"PP1-docking motif RVXF, 976-982, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,COSMIC,,,"hg38,12:131920104-131920104","hg38,12:g.131920104G>A",0.593,skin,malignant_melanoma,0.0000120151871966,
1064,978,R,,,,,,,,,,,s,"PCSK cleavage site, 978-982, ELM|PP1-docking motif RVXF, 976-982, ELM|14-3-3 binding phosphopeptide motif, 978-988, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,,,,,,,,,,
1065,979,L,,,,,,,,,,,s,"PCSK cleavage site, 978-982, ELM|PP1-docking motif RVXF, 976-982, ELM|14-3-3 binding phosphopeptide motif, 978-988, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,,,,,,,,,,
1066,980,I,,,,,,,,,,,s,"PCSK cleavage site, 978-982, ELM|PP1-docking motif RVXF, 976-982, ELM|14-3-3 binding phosphopeptide motif, 978-988, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 975-980, ELM",,,,,,,,,,,
1067,981,F,,,,,,,,,,,s,"PCSK cleavage site, 978-982, ELM|PP1-docking motif RVXF, 976-982, ELM|14-3-3 binding phosphopeptide motif, 978-988, ELM",,,,,,,,,,,
1068,982,S,,,,,,,,,,,s,"PCSK cleavage site, 978-982, ELM|PP1-docking motif RVXF, 976-982, ELM|14-3-3 binding phosphopeptide motif, 978-988, ELM",,,,,,,,,,,
1069,983,H,N,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,"cBioPortal,COSMIC",gbm_tcga_pan_can_atlas_2018,Glioblastoma Multiforme,"hg19,12:132404667-132404667, hg38,12:131920122-131920122","hg19,12:g.132404667C>A, hg38,12:g.131920122C>A",0.206,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1070,984,A,S,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,COSMIC,,,"hg38,12:131920125-131920125","hg38,12:g.131920125G>T",0.534,thyroid,"carcinoma, anaplastic_carcinoma",,
1071,985,V,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,,,,,,,,,,
1072,986,Q,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,,,,,,,,,,
1073,987,M,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,,,,,,,,,,
1074,988,V,A,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 978-988, ELM",,COSMIC,,,"hg38,12:131921101-131921101","hg38,12:g.131921101T>C",0.332,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000043845034111,
1075,989,Q,,,,,,,,,,,s,,,,,,,,,,,,
1076,990,S,,,,,,,,,,,s,,,,,,,,,,,,
1077,991,A,,,,,,,,,,,s,,,,,,,,,,,,
1078,992,A,,,,,,,,,,,s,,,,,,,,,,,,
1079,993,L,V,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921115-131921115","hg38,12:g.131921115C>G",0.294,"oesophagus, upper_third","carcinoma, squamous_cell_carcinoma",,
1080,994,D,,,,,,,,,,,s,,,,,,,,,,,,
1081,995,E,G,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921122-131921122","hg38,12:g.131921122A>G",0.712,prostate,"carcinoma, adenocarcinoma",,
1082,996,M,,,,,,,,,,,s,,,,,,,,,,,,
1083,997,F,S,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921128-131921128","hg38,12:g.131921128T>C",0.467,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1084,998,Q,,,,,,,,,,,s,,,,,,,,,,,,
1085,999,H,,,,,,,,,,,s,,,,,,,,,,,,
1086,1000,R,H,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, ccle_broad_2019, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,12:132405682-132405682, hg38,12:131921137-131921137","hg19,12:g.132405682G>A, hg38,12:g.131921137G>A",0.105,"lung, urinary_tract, bladder","carcinoma, carcinoma, mixed_adenosquamous_carcinoma",0.0000249270882668,0.0000318755578223
1087,1001,E,,,,,,,,,,,s,,,,,,,,,,,,
1088,1002,G,D,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921143-131921143","hg38,12:g.131921143G>A",0.080,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000041408896287,
1089,1003,C,,,,,,,,,,,s,,,,,,,,,,,,
1090,1004,V,I,,,,,,,,,,s,,,"cBioPortal,COSMIC","cesc_tcga_pan_can_atlas_2018, lihc_tcga_pan_can_atlas_2018, prostate_pcbm_swiss_2019","Cervical Squamous Cell Carcinoma, Hepatocellular Carcinoma, Prostate","hg19,12:132405693-132405693, hg38,12:131921148-131921148","hg19,12:g.132405693G>A, hg38,12:g.131921148G>A",0.086,"cervix, liver","carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma",0.0002228844550475,0.0000637470516989
1091,1005,P,,,,,,,,,,,s,,,,,,,,,,,,
1092,1006,R,C,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM",,"cBioPortal,COSMIC","ucec_tcga_pan_can_atlas_2018, ucs_tcga, ucs_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,12:132405699-132405699, hg38,12:131921154-131921154","hg19,12:g.132405699C>T, hg38,12:g.131921154C>T",0.422,endometrium,"carcinoma, endometrioid_carcinoma",0.0000287959192069,
1093,1007,Y,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1094,1008,H,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1095,1009,K,,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1096,1010,A,S,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|SUMO interaction site, 1010-1015, ELM|eIF4E binding motif, 1007-1013, ELM",,"cBioPortal,COSMIC","esca_tcga, esca_tcga_pan_can_atlas_2018, luad_broad, nsclc_tcga_broad_2016, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,12:132405711-132405711, hg38,12:131921166-131921166","hg19,12:g.132405711G>T, hg38,12:g.131921166G>T",0.496,lung,"carcinoma, adenocarcinoma",,
1097,1010,A,V,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|SUMO interaction site, 1010-1015, ELM|eIF4E binding motif, 1007-1013, ELM",,cBioPortal,"esca_tcga, esca_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,12:132405712-132405712","hg19,12:g.132405712C>T",0.542,,,,
1098,1011,L,,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|Clathrin box, 1011-1015, ELM|SUMO interaction site, 1010-1015, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1099,1012,L,,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|Clathrin box, 1011-1015, ELM|SUMO interaction site, 1010-1015, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1100,1013,L,,,,,,,,,,,s,"PCSK cleavage site, 1009-1013, ELM|Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|Clathrin box, 1011-1015, ELM|SUMO interaction site, 1010-1015, ELM|eIF4E binding motif, 1007-1013, ELM",,,,,,,,,,,
1101,1014,L,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|MAPK docking motifs, 1006-1014, ELM|Clathrin box, 1011-1015, ELM|SUMO interaction site, 1010-1015, ELM",,,,,,,,,,,
1102,1015,E,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 1006-1015, ELM|Clathrin box, 1011-1015, ELM|SUMO interaction site, 1010-1015, ELM",,,,,,,,,,,
1103,1016,G,R,,,,,,,,,,s,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,12:132405729-132405729, hg38,12:131921184-131921184","hg19,12:g.132405729G>A, hg38,12:g.131921184G>A",0.701,skin,malignant_melanoma,,
1104,1017,L,,,,,,,,,,,s,,,,,,,,,,,,
1105,1018,Q,,,,,,,,,,,s,,,,,,,,,,,,
1106,1019,H,,,,,,,,,,,s,,,,,,,,,,,,
1107,1020,M,I,,,,,,,,,,s,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,12:132405743-132405743, hg38,12:131921198-131921198","hg19,12:g.132405743G>T, hg38,12:g.131921198G>T",0.065,"liver, lung","carcinoma, large_cell_carcinoma, other, neoplasm",,
1108,1021,L,,,,,,,,,,,s,,,,,,,,,,,,
1109,1022,S,L,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921203-131921203","hg38,12:g.131921203C>T",0.035,stomach,carcinoma,0.0000488965674610,0.0002231289047558
1110,1023,D,,,,,,,,,,,s,,,,,,,,,,,,
1111,1024,Q,,,,,,,,,,,s,,,,,,,,,,,,
1112,1025,A,,,,,,,,,,,s,,,,,,,,,,,,
1113,1026,D,N,,,,,,,,,,s,,,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,12:132405759-132405759, hg38,12:131921214-131921214","hg19,12:g.132405759G>A, hg38,12:g.131921214G>A",0.525,oesophagus,"carcinoma, adenocarcinoma",0.0000081365640917,
1114,1027,I,,,,,,,,,,,s,,,,,,,,,,,,
1115,1028,E,V,,,,,,,,,,s,,,COSMIC,,,"hg38,12:131921221-131921221","hg38,12:g.131921221A>T",0.258,large_intestine,"carcinoma, adenocarcinoma",0.0001014676277680,
1116,1029,N,,,,,,,,,,,s,,,,,,,,,,,,
1117,1030,V,,,,,,,,,,,s,,,,,,,,,,,,
1118,1031,T,,,,,,,,,,,s,,,,,,,,,,,,
1119,1032,K,R,,,,,,,,,,s,,,"cBioPortal,COSMIC",gbm_tcga_pan_can_atlas_2018,Glioblastoma Multiforme,"hg19,12:132405778-132405778, hg38,12:131921233-131921233","hg19,12:g.132405778A>G, hg38,12:g.131921233A>G",0.204,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1120,1033,C,,,,,,,,,,,s,,,,,,,,,,,,
1121,1034,K,,,,,,,,,,,s,,,,,,,,,,,,
1122,1035,L,P,,,,,,,,,,s,,,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,12:132405857-132405857","hg19,12:g.132405857T>C",0.166,,,,
1123,1036,C,,,,,,,,,,,s,,,,,,,,,,,,
1124,1037,I,,,,,,,,,,,s,,,,,,,,,,,,
1125,1038,E,,,,,,,,,,,s,,,,,,,,,,,,
1126,1039,R,W,,,,,,,,,,s,"NRD cleavage site, 1039-1041, ELM|14-3-3 binding phosphopeptide motif, 1039-1048, ELM|di Arginine retention/retrieving signal, 1039-1041, ELM",,"cBioPortal,COSMIC",stad_tcga_pub,Stomach Adenocarcinoma,"hg19,12:132405868-132405868, hg38,12:131921323-131921323","hg19,12:g.132405868C>T, hg38,12:g.131921323C>T",0.404,stomach,"carcinoma, adenocarcinoma",0.0000040626955172,
1127,1040,R,,,,,,,,,,,s,"NRD cleavage site, 1039-1041, ELM|14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM|di Arginine retention/retrieving signal, 1039-1041, ELM",,,,,,,,,,,
1128,1041,L,,,,,,,,,,,s,"NRD cleavage site, 1039-1041, ELM|14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM|di Arginine retention/retrieving signal, 1039-1041, ELM",,,,,,,,,,,
1129,1042,S,T,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,12:132405877-132405877","hg19,12:g.132405877T>A",0.080,,,,
1130,1043,A,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM",,,,,,,,,,,
1131,1044,L,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM",,,,,,,,,,,
1132,1045,L,V,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM|PDZ domain ligands, 1045-1050, ELM",,COSMIC,,,"hg38,12:131921341-131921341","hg38,12:g.131921341C>G",0.086,"central_nervous_system, cerebellum","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1133,1046,T,,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|Nuclear receptor box, 1040-1046, ELM|PDZ domain ligands, 1045-1050, ELM",,,,,,,,,,,
1134,1047,G,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|PDZ domain ligands, 1045-1050, ELM",,,,,,,,,,,
1135,1048,I,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 1039-1048, ELM|14-3-3 binding phosphopeptide motif, 1040-1048, ELM|PDZ domain ligands, 1045-1050, ELM",,,,,,,,,,,
1136,1049,C,,,,,,,,,,,s,"PDZ domain ligands, 1045-1050, ELM",,,,,,,,,,,
1137,1050,A,T,,,,,,,,,,s,"PDZ domain ligands, 1045-1050, ELM",,COSMIC,,,"hg38,12:131921356-131921356","hg38,12:g.131921356G>A",0.173,stomach,carcinoma,,
